1
|
Meinders MJ, Heathers L, Ho KC, Russell L, Li C, Bloem BR, Marks WJ, Kapur R. Optimizing wrist-worn wearable compliance with insights from two Parkinson's disease cohort studies. NPJ Parkinsons Dis 2025; 11:152. [PMID: 40480983 PMCID: PMC12144100 DOI: 10.1038/s41531-025-01016-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Accepted: 05/03/2025] [Indexed: 06/11/2025] Open
Abstract
Wearable technologies enable real-time, continuous, noninvasive data collection, where long-term compliance is essential. The Personalized Parkinson Project (PPP) and the Parkinson's Progression Markers Initiative (PPMI) utilized the Verily Study Watch. Participants, including people diagnosed with Parkinson's disease (PD), prodromal PD, and healthy controls, were instructed to wear the watch for up to 23 h daily without data displaying or reporting data back to the participant. Compliance measures and user experiences were evaluated. A centralized support model identified barriers to data collection and enabled proactive outreach. Median daily wear time was 21.9 h for PPP and 21.1-22.2 h per day for PPMI over 2 years. Participants were highly motivated contributing to PD research. These results highlight strategies for achieving strong engagement without providing individual data. This approach offers valuable insights for study designs where returning data to participants could introduce bias or affect the data integrity.
Collapse
Affiliation(s)
- Marjan J Meinders
- Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.
| | - Laura Heathers
- Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, Indiana, IN, USA
| | - King Chung Ho
- Verily Life Sciences, South San Francisco, San Francisco, CA, USA
| | - Laura Russell
- Verily Life Sciences, South San Francisco, San Francisco, CA, USA
| | - Chris Li
- Verily Life Sciences, South San Francisco, San Francisco, CA, USA
| | - Bastiaan R Bloem
- Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands
| | | | - Ritu Kapur
- Verily Life Sciences, South San Francisco, San Francisco, CA, USA
| |
Collapse
|
2
|
Elbarbary NS, Khattab DA, Sultan BM, Rahman Ismail EA. Periodontal disease in adolescents with type 1 diabetes mellitus: A cross link between continuous glucose monitoring-derived metrics, caspase-3 levels, diabetic nephropathy and subclinical atherosclerosis. Diabetes Res Clin Pract 2025; 224:112234. [PMID: 40339704 DOI: 10.1016/j.diabres.2025.112234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2025] [Revised: 04/16/2025] [Accepted: 05/03/2025] [Indexed: 05/10/2025]
Abstract
BACKGROUND Periodontitis can lead to the development of atherosclerotic heart disease. AIM To assess the relation between periodontal disease and continuous glucose monitoring (CGM)-derived metrics, caspase-3 and carotid intima media thickness (CIMT) in adolescents with type 1 diabetes mellitus (T1DM). METHODS This cross-sectional study included 115 participants with T1DM (15.91 ± 2.14 years). CIMT, CGM-derived metrics, periodontal probing depths (PPD) and amount of loss clinical attachment (CAL) were assessed. Serum caspase-3 levels were measured in T1DM participants compared with 40 healthy controls. RESULTS Periodontitis was found in 69.6 % of T1DM group. Serum caspase-3 levels were significantly elevated in T1DM participants compared with controls (median 8.4 versus 1.2 ng/mL; p < 0.001. Participants with periodontitis had higher percentage of nephropathy with elevated CIMT, caspase-3 levels, glucose management indicator (GMI) (7.5 ± 0.58 versus 7.1 ± 0.51 %; p = 0.047), coefficient of variation (CV) (36.4 ± 5.6 versus 33.2 ± 5.9 %; p = 0.008) and glycemic risk index while time in range (TIR) was significantly lower (58.5 ± 14.1 versus 69.7 ± 11.5 %; p = 0.002) compared with those without periodontitis. Participants using advanced hybrid close loop system had lower caspase 3 levels and CIMT compared with those on multiple daily injections. There were positive correlations between caspase-3 and GMI (r = 0.587), CV (r = 0.434), CIMT (r = 0.425), PPD (r = 0.952) and CAL (r = 0.739) while caspase-3 was negatively correlated to TIR(r = -0.481; p < 0.001 for all). CONCLUSION Periodontitis is prevalent among adolescents with T1DM and is linked to glycemic variability and poor metabolic control while associated with diabetic nephropathy and subclinical atherosclerosis. Elevated caspase-3 highlights the involvement of apoptosis in periodontal disease and subclinical atherosclerosis in T1DM.
Collapse
Affiliation(s)
| | - Doaa Adel Khattab
- Oral Medicine, Periodontology and Diagnosis Department, Faculty of Dentistry, Ain Shams University, Cairo, Egypt
| | - Basma Mohamed Sultan
- Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | | |
Collapse
|
3
|
Moon SJ, Kim MS, Kim YT, Lee HE, Lee YW, Lee SJ, Chung ES, Park CY. Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial. Cardiovasc Diabetol 2025; 24:210. [PMID: 40369552 PMCID: PMC12079838 DOI: 10.1186/s12933-025-02747-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/15/2024] [Accepted: 04/18/2025] [Indexed: 05/16/2025] Open
Abstract
BACKGROUND Maintaining optimal glucose control is critical for postoperative care cardiac surgery patients. Continuous glucose monitoring (CGM) in this setting remains understudied. We evaluated the efficacy of CGM with a specialized titration protocol in cardiac surgery patients with type 2 diabetes (T2D) and prediabetes. METHODS In this randomized-controlled trial, 54 cardiac surgery patients were randomized one day post-surgery, with 27 CGM and 25 point-of-care (POC) patients completing the study. The CGM group used Dexcom G6 with a CGM-specialized titration protocol, while the POC group used standard monitoring with blinded CGM. The primary outcome was time-in-range (TIR) 100-180 mg/dL for 7 days post-surgery. Secondary outcomes included various glycemic metrics and surgical outcomes. Multiple comparison adjustments were performed using false-discovery-rate (FDR). RESULTS Thirty-one (59.6%) had diabetes and 21 (40.4%) had prediabetes. While TIR 100-180 mg/dL showed no difference (74.7% vs. 71.6%, FDR-adjusted p = 0.376), the CGM group demonstrated improvements in TIR 70-180 mg/dL (83.8% vs. 75.8%, FDR-adjusted p = 0.026), time-in-tight-range (TITR) 100-140 mg/dL (46.3% vs. 36.3%, FDR-adjusted p = 0.018), and TITR 70-140 mg/dL (55.3% vs. 40.5%, FDR-adjusted p = 0.003). Both groups maintained very low rates of time below range (< 70 mg/dL: 0.03% vs. 0.18%, FDR-adjusted p = 0.109). The CGM group showed lower postoperative atrial fibrillation (AF) (18.8% vs. 55.6%, FDR-adjusted p = 0.04999). CONCLUSION While the primary outcome was not achieved, CGM with a specialized titration protocol demonstrated safe glycemic control with improvements in TIR 70-180 mg/dL and TITRs in cardiac surgery patients with T2D and prediabetes. The observed reduction in postoperative AF warrants further investigation. TRIAL REGISTRATION ClinicalTrials.gov NCT06275971.
Collapse
Affiliation(s)
- Sun-Joon Moon
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea
| | - Min-Su Kim
- Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea
| | - Yun Tae Kim
- Division of Biostatistics, Department of Academic Research, Kangbuk Samsung Hospital, Seoul, Republic of Korea
| | - Ha-Eun Lee
- Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea
| | - Young-Woo Lee
- Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea
| | - Su-Ji Lee
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea
| | - Euy-Suk Chung
- Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea.
| | - Cheol-Young Park
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea.
| |
Collapse
|
4
|
Lee J, Liberty LM, Soltis I, Kwon K, Chong D, Kwon Y, Yeo WH. Wireless Flexible Potentiometric Microsensors for Temperature-Compensated Sweat Electrolyte Monitoring. ACS APPLIED MATERIALS & INTERFACES 2025. [PMID: 40347141 DOI: 10.1021/acsami.5c03558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2025]
Abstract
Sweat electrolyte analysis using potentiometric systems is a promising approach for continuous health monitoring. However, despite its potential, temperature-induced measurement errors remain a critical challenge, and, to our knowledge, no study has effectively addressed this issue for accurate potentiometric sensing during physiological activities. Here, we present a temperature-compensated flexible microsensor integrated with a wireless potentiometric measurement circuit for real-time sweat analysis. The wearable system features an array of microsensors for simultaneous detection of pH, Na+, K+, and skin temperature, enabling real-time dynamic temperature compensation. A PEDOT:PSS/graphene ion-to-charge transducer enhances sensitivity through superior electron acceptor properties and an expanded electroactive surface area. The incorporation of a Nafion top layer ensures 2-week-long stability by facilitating selective cation transport while mitigating sensor degradation. With temperature compensation, the wireless wearable device measures an accurate level of electrolytes under extreme temperature variations (8 to 56 °C), including outdoor exercises and exposure to dry saunas, to assess the necessity of temperature correction. This work collectively establishes a robust, high-performance platform for continuous monitoring of sweat biomarkers, thus advancing wearable diagnostic technology for personalized healthcare applications.
Collapse
Affiliation(s)
- Jimin Lee
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| | - Leel Mazal Liberty
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| | - Ira Soltis
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| | - Kangkyu Kwon
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| | - David Chong
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| | - Youngjin Kwon
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| | - Woon-Hong Yeo
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Wearable Intelligent Systems and Healthcare Center (WISH Center) at the Institute for Matter and Systems, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia 30332, United States
- Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
- Korea KIAT-Georgia Tech Semiconductor Electronics Center (K-GTSEC), Georgia Institute of Technology, Atlanta, Georgia 30332, United States
| |
Collapse
|
5
|
Koiwa D, Haga Y, Tsuruoka N. Measurement of lactate concentration using a minimally invasive needle with non-planer optical waveguides. Biosens Bioelectron 2025; 285:117557. [PMID: 40381576 DOI: 10.1016/j.bios.2025.117557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2025] [Revised: 05/01/2025] [Accepted: 05/04/2025] [Indexed: 05/20/2025]
Abstract
Traditional methods for sampling biological substance concentrations in blood are invasive and unsuitable for continuous monitoring. This paper presents a minimally invasive device equipped with optical waveguides on the surface of an acupuncture needle for measuring lactate concentration in subepidermal tissue, potentially in a continuous fashion. The device utilizes absorbance measurements, based on the correlation between absorbance and lactate concentration in tissue. The needle, with a diameter of 200 μm, exhibits good penetrability, particularly when coated with a biocompatible epoxy, which reduces insertion resistance. The experimental results demonstrate that the device can successfully measure the concentration of lactate solutions, with light intensity decreasing as the lactate concentration increases. However, challenges remain in optimizing the device to reduce optical losses and enhance measurement accuracy. Future work will focus on reducing optical loss, conducting animal experiments, and developing a miniaturized system for simultaneous measurement of multiple biological substances, aiming for practical applications in daily health monitoring.
Collapse
Affiliation(s)
- Daigo Koiwa
- Graduate School of Engineering, Tohoku University, 6-6 Aza-Aoba, Aramaki, Aoba-ku, Sendai, Miagi, Japan
| | - Yoichi Haga
- Graduate School of Engineering, Tohoku University, 6-6 Aza-Aoba, Aramaki, Aoba-ku, Sendai, Miagi, Japan
| | - Noriko Tsuruoka
- Graduate School of Engineering, Tohoku University, 6-6 Aza-Aoba, Aramaki, Aoba-ku, Sendai, Miagi, Japan.
| |
Collapse
|
6
|
Kim JY, Kim S, Kim JH. Comparison of Real-Time and Intermittently-Scanned Continuous Glucose Monitoring for Glycemic Control in Type 1 Diabetes Mellitus: Nationwide Cohort Study. Diabetes Metab J 2025; 49:436-447. [PMID: 40012108 PMCID: PMC12086561 DOI: 10.4093/dmj.2024.0160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Accepted: 10/30/2024] [Indexed: 02/28/2025] Open
Abstract
BACKGRUOUND This study compares the association between real-time continuous glucose monitoring (rtCGM) and intermittently- scanned CGM (isCGM) and glycemic control in individuals with type 1 diabetes mellitus (T1DM) in a real-world setting. METHODS Using data from the Korean National Health Insurance Service Cohort, individuals with T1DM managed by intensive insulin therapy were followed at 3-month intervals for 2 years after the initiation of CGM. The glycosylated hemoglobin (HbA1c) levels and coefficients of variation (CVs) of rtCGM and isCGM users were compared using independent two-sample t-test and a linear mixed model. RESULTS The analyses considered 7,786 individuals (5,875 adults aged ≥19 years and 1,911 children and adolescents aged <19 years). Overall, a significant reduction in HbA1c level was observed after 3 months of CGM, and the effect was sustained for 2 years. The mean HbA1c level at baseline was higher in rtCGM users than in isCGM users (8.9%±2.7% vs. 8.6%±2.2%, P<0.001). However, from 3 to 24 months, rtCGM users had lower HbA1c levels than isCGM users at every time point (7.1%±1.2% vs. 7.5%±1.3% at 24 months, P<0.001 for all time points). In both adults and children, the greater reduction in HbA1c with rtCGM remained significant after adjusting for the baseline characteristics of the users. The CV also showed greater decrease with rtCGM than with isCGM. CONCLUSION In this large nationwide cohort study, the use of rtCGM was associated with a greater improvement in glycemic control, including HbA1c reduction, than the use of isCGM in both adults and children with T1DM.
Collapse
Affiliation(s)
- Ji Yoon Kim
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Seohyun Kim
- Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea
| | - Jae Hyeon Kim
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea
| |
Collapse
|
7
|
Zeng J, Kosak T, Malkani S, Hudson JC, Martin NE, Tishler RB, Pashtan IM. Management of Continuous Glucose Monitors in Radiation Oncology Patients. Pract Radiat Oncol 2025; 15:e295-e299. [PMID: 39142390 DOI: 10.1016/j.prro.2024.06.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2024] [Revised: 05/17/2024] [Accepted: 06/07/2024] [Indexed: 08/16/2024]
Abstract
Continuous glucose monitors (CGMs) are an increasingly prevalent electronic medical device used by patients with diabetes, offering several advantages over "finger sticks." There is a resulting rise in patients with CGMs seen in radiation oncology clinics. Manufacturers specify that CGMs should not be exposed to radiation (both diagnostic and therapeutic) due to the risk of device damage, creating challenges for patients and providers. We present a workflow for the management of CGMs in radiation oncology patients, beginning with systematic screening by providers and staff. We propose options for CGM management together with the device prescriber, including removal of the CGM or keeping it in place with periodic finger sticks to confirm the accuracy and offer guidance to radiation oncology providers and staff.
Collapse
Affiliation(s)
- Johnathan Zeng
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Tara Kosak
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Samir Malkani
- Division of Diabetes, Endocrinology, and Metabolism, University of Massachusetts Medical School, Worcester, Massachusetts
| | - Julie C Hudson
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Neil E Martin
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Roy B Tishler
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Itai M Pashtan
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
| |
Collapse
|
8
|
Li L, Chen J, Guan T, Yu Z, Zhang J, Ji R, Li Z, Lei M, Zheng P, Li Y, Gao F. WITHDRAWN: A Machine Learning Model for Real-Time Hypoglycemia Risk Prediction in Hospitalized Diabetic Patients: Development and Validation. RESEARCH SQUARE 2025:rs.3.rs-6171081. [PMID: 40162207 PMCID: PMC11952634 DOI: 10.21203/rs.3.rs-6171081/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/02/2025]
Abstract
The full text of this preprint has been withdrawn, as it was submitted in error. Therefore, the authors do not wish this work to be cited as a reference. Questions should be directed to the corresponding author.
Collapse
|
9
|
Zhi Y, Xie S, Wei B. Electrochemical biosensors for enhanced detection of diabetes mellitus. Clin Chim Acta 2025; 571:120221. [PMID: 40024276 DOI: 10.1016/j.cca.2025.120221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2025] [Revised: 02/25/2025] [Accepted: 02/27/2025] [Indexed: 03/04/2025]
Abstract
The worldwide incidence of diabetes mellitus (DM), as a long-term metabolic condition, continues to rise, creating an urgent need for accurate and efficient diagnostic methods to identify and treat the disease early. Among various analytical technologies, electrochemical biosensors stand out for their exceptional attributes, including precise detection, selective response, quick results, and affordable implementation. The current review study examines the latest developments in electrochemical biosensor technology designed specifically for diabetes detection, emphasizing novel approaches in blood sugar monitoring and tracking key diabetes indicators, including HbA1c, insulin levels, and ketones. The discussion encompasses cutting-edge developments such as sensors incorporating nanomaterials, non-enzymatic detection systems, and portable monitoring devices, emphasizing how these innovations improve both technical capabilities and patient experience. This review also demonstrates how next-generation electrochemical biosensors could fundamentally change diabetes care and monitoring, leading to more widely available and accurate disease tracking methods.
Collapse
Affiliation(s)
- Yong Zhi
- Xinjiang 474 Hospital, Urumqi, Xinjiang 830011, China; College of Traditional Chinese Medicine, Xinjiang Medical University, Xinjiang 830017, China.
| | - Shanshan Xie
- Xinjiang Key Laboratory of Mental Development and Learning Science, Xinjiang Normal University, Urumqi, Xinjiang 830000, China
| | - Bowen Wei
- Independent Research, Jilin 132100, China.
| |
Collapse
|
10
|
Cătălina GR, Gheorman V, Gheorman V, Forțofoiu MC. The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases. Healthcare (Basel) 2025; 13:837. [PMID: 40218134 PMCID: PMC11988559 DOI: 10.3390/healthcare13070837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2025] [Revised: 03/08/2025] [Accepted: 04/02/2025] [Indexed: 04/14/2025] Open
Abstract
Psychiatric disorders and internal diseases frequently co-occur, posing significant challenges due to overlapping symptoms, shared pathophysiological mechanisms, and increased healthcare burdens. Neuroinflammation has emerged as a central mechanism linking these conditions, driven by systemic inflammation, hypothalamic-pituitary-adrenal (HPA) axis dysregulation, and autonomic nervous system (ANS) imbalance. This review synthesizes current evidence on the role of neuroinflammation in comorbid conditions such as depression, anxiety, cardiovascular disease, and diabetes mellitus, emphasizing bidirectional relationships and shared inflammatory pathways. This analysis identifies gaps in longitudinal studies, biomarker validation, and the integration of multidisciplinary care models. Emerging therapeutic approaches, including IL-6 inhibitors, vagus nerve stimulation, and behavioral interventions, show promise but remain underexplored in combined applications. Furthermore, disparities in research representation limit the generalizability of findings and highlight the need for inclusive clinical trials. Addressing these gaps through precision medicine, advanced biomarker monitoring technologies, and equitable healthcare strategies could transform the management of these complex comorbidities. By advancing our understanding of neuroinflammatory mechanisms and promoting integrated interventions, this review underscores the need for a collaborative, patient-centered approach to improve outcomes and reduce the global burden of psychiatric and internal disease comorbidities.
Collapse
Affiliation(s)
| | - Victor Gheorman
- Department of Psychiatry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
| | - Veronica Gheorman
- Department of Medical Semiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
| | - Mircea-Cătălin Forțofoiu
- Department of Medical Semiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
| |
Collapse
|
11
|
Molu B, Molu G. An evaluation of YouTube videos on glucose sensor devices and type 1 diabetes mellitus: User perceptions, device features, and content reliability. Diabetes Res Clin Pract 2025; 222:112069. [PMID: 40010671 DOI: 10.1016/j.diabres.2025.112069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/07/2025] [Revised: 02/20/2025] [Accepted: 02/24/2025] [Indexed: 02/28/2025]
Abstract
AIM The aim of this study is to evaluate the performance, comprehensiveness, reliability, and quality of English-language YouTube videos related to new glucose sensor devices. METHODS In November 2024, a search was conducted on a computer using the keywords "glucose sensor devices," "continuous glucose monitor," "glucose sensor devices and Type 1 Diabetes Mellitus," and "glucose sensor devices and child." Based on the inclusion and exclusion criteria, 30 videos that met the research objectives were analyzed. Relevant URLs were recorded. For each video, the following information was collected. RESULTS Of the 30 videos analyzed, 40 % (n = 12) were presented or managed by healthcare professionals. The average values for performance features of the videos were: 172,257.166 ± 233,861.720 views, 170.866 ± 222.974 comments, and 1,643.133 ± 2,252.247 likes. Four videos did not receive any likes. 40 % of the videos contained good and useful information for viewers, while 60 % were of high quality. CONCLUSION This study demonstrates that detailed and reliable content in YouTube videos about glucose monitoring devices enhances quality. It is recommended that video content be regularly evaluated, and future research should be conducted using alternative measurement tools in different languages.
Collapse
Affiliation(s)
- Birsel Molu
- Selcuk University Akşehir Kadir Yallagöz Health School, Türkiye.
| | - Gizem Molu
- AFSU Health Application and Research Center, Türkiye.
| |
Collapse
|
12
|
Afridi Z, Rauf SA, Ashraf SMN, Haque MA. Transformative Advances in Continuous Glucose Monitoring and the Impact of FDA Over-the-Counter Approval on Diabetes Care. Health Sci Rep 2025; 8:e70747. [PMID: 40256128 PMCID: PMC12007415 DOI: 10.1002/hsr2.70747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Revised: 01/24/2025] [Accepted: 04/10/2025] [Indexed: 04/22/2025] Open
Abstract
Introduction Continuous glucose monitoring (CGM) has significantly advanced diabetes management, evolving from early glucose testing methods to modern, FDA-approved systems. Despite its benefits, challenges related to data security, affordability, and awareness of CGM devices remain. Aim This article explores the historical development, current advancements, and ongoing challenges of CGM systems in diabetes management. It aims to provide insights into how these technologies have transformed patient care and highlight areas needing further improvement. Methods A comprehensive literature review was conducted, focusing on advancements in CGM technology. Sources included PubMed, Google Scholar, and recent guidelines and reviews on CGM systems and their impact on diabetes management. Results The evolution from the Dextrostix test strip to modern CGM systems, including over-the-counter devices, has enhanced glucose monitoring and patient outcomes. Recent innovations, such as machine learning models for predicting glucose fluctuations, promise to improve diabetes management. However, issues like data security and device accessibility persist. Conclusion To maximize the benefits of CGM systems, addressing data security, improving affordability, and increasing awareness of CGM devices are crucial. Continued advancements in CGM technology and supportive policies are essential for enhancing diabetes care and patient outcomes globally.
Collapse
Affiliation(s)
- Zain Afridi
- Department of MedicineKhyber Medical CollegePeshawarKarachiPakistan
| | - Sameer Abdul Rauf
- Department of MedicineLiaquat National Medical CollegeKarachiPakistan
| | | | - Md Ariful Haque
- Department of Public HealthAtish Dipankar University of Science and TechnologyDhakaBangladesh
- Voice of Doctors Research SchoolDhakaBangladesh
- Department of Orthopaedic SurgeryYan'an Hospital Affiliated to Kunming Medical UniversityKunmingYunnanChina
| |
Collapse
|
13
|
Lazar S, Potre O, Ionita I, Reurean-Pintilei DV, Timar R, Herascu A, Avram VF, Timar B. The Usefulness of the Glucose Management Indicator in Evaluating the Quality of Glycemic Control in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring Sensors: A Cross-Sectional, Multicenter Study. BIOSENSORS 2025; 15:190. [PMID: 40136987 PMCID: PMC11940097 DOI: 10.3390/bios15030190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/07/2024] [Revised: 03/13/2025] [Accepted: 03/14/2025] [Indexed: 03/27/2025]
Abstract
The Glucose Management Indicator (GMI) is a biomarker of glycemic control which estimates hemoglobin A1c (HbA1c) based on the average glycemia recorded by continuous glucose monitoring sensors (CGMS). The GMI provides an immediate overview of the patient's glycemic control, but it might be biased by the patient's sensor wear adherence or by the sensor's reading errors. This study aims to evaluate the GMI's performance in the assessment of glycemic control and to identify the factors leading to erroneous estimates. In this study, 147 patients with type 1 diabetes, users of CGMS, were enrolled. Their GMI was extracted from the sensor's report and HbA1c measured at certified laboratories. The median GMI value overestimated the HbA1c by 0.1 percentage points (p = 0.007). The measurements had good reliability, demonstrated by a Cronbach's alpha index of 0.74, an inter-item correlation coefficient of 0.683 and an inter-item covariance between HbA1c and GMI of 0.813. The HbA1c and the difference between GMI and HbA1c were reversely associated (Spearman's r = -0.707; p < 0.001). The GMI is a reliable tool in evaluating glycemic control in patients with diabetes. It tends to underestimate the HbA1c in patients with high HbA1c values, while it tends to overestimate the HbA1c in patients with low HbA1c.
Collapse
Affiliation(s)
- Sandra Lazar
- First Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (S.L.); (I.I.)
- Department of Hematology, Emergency Municipal Hospital, 300254 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (R.T.); (A.H.); (V.F.A.); (B.T.)
| | - Ovidiu Potre
- First Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (S.L.); (I.I.)
- Department of Hematology, Emergency Municipal Hospital, 300254 Timisoara, Romania
- Multidisciplinary Research Center for Malignant Hematological Diseases (CCMHM), Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Ioana Ionita
- First Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (S.L.); (I.I.)
- Department of Hematology, Emergency Municipal Hospital, 300254 Timisoara, Romania
- Multidisciplinary Research Center for Malignant Hematological Diseases (CCMHM), Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Delia-Viola Reurean-Pintilei
- Department of Medical-Surgical and Complementary Sciences, Faculty of Medicine and Biological Sciences, “Stefan cel Mare” University, 720229 Suceava, Romania;
- Department of Diabetes, Nutrition and Metabolic Diseases, Consultmed Medical Centre, 700544 Iasi, Romania
| | - Romulus Timar
- Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (R.T.); (A.H.); (V.F.A.); (B.T.)
- Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Department of Diabetes, “Pius Brinzeu” Emergency Hospital, 300723 Timisoara, Romania
| | - Andreea Herascu
- Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (R.T.); (A.H.); (V.F.A.); (B.T.)
- Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Department of Diabetes, “Pius Brinzeu” Emergency Hospital, 300723 Timisoara, Romania
| | - Vlad Florian Avram
- Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (R.T.); (A.H.); (V.F.A.); (B.T.)
- Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Department of Diabetes, “Pius Brinzeu” Emergency Hospital, 300723 Timisoara, Romania
| | - Bogdan Timar
- Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (R.T.); (A.H.); (V.F.A.); (B.T.)
- Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Department of Diabetes, “Pius Brinzeu” Emergency Hospital, 300723 Timisoara, Romania
| |
Collapse
|
14
|
Xiao Y, Wang Z, Zhang L, Xie N, Chen F, Song Z, Zhao S. Effectiveness of Digital Diabetes Management Technology on Blood Glucose in Patients With Type 2 Diabetes at Home: Systematic Review and Meta-Analysis. J Med Internet Res 2025; 27:e66441. [PMID: 40053775 PMCID: PMC11914849 DOI: 10.2196/66441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2024] [Revised: 12/19/2024] [Accepted: 02/03/2025] [Indexed: 03/09/2025] Open
Abstract
BACKGROUND Patients with type 2 diabetes mellitus (T2DM) face elevated morbidity, mortality, and care costs. Digital self-monitoring of blood glucose (SMBG) can automatically upload data to apps, share the data with health care providers, reduce errors, and aid long-term diabetes management. OBJECTIVE This study aimed to assess the effectiveness of digital diabetes management techniques based on digital SMBG on blood glucose in patients with T2DM at home. METHODS A systematic search was conducted in PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, China Biomedical Literature Database, and Cochrane Library for articles published from the establishment of each database to December 25, 2023. Data were extracted independently by 2 researchers (YX and NX), and the risk of bias in individual trials was rated using the Cochrane risk-of-bias tool. A meta-analysis was conducted using RevMan 5.3 (Cochrane). RESULTS Twelve studies were included, involving 1669 participants. The meta-analysis found that in the digital diabetes management group, hemoglobin A1c (mean difference [MD] -0.52%, 95% CI -0.63% to -0.42%; P<.001), fasting blood sugar (MD -0.42, 95% CI -0.65 to -0.19 mmol/L; P<.001), 2-hour postprandial blood sugar (MD -0.64, 95% CI -0.97 to -0.32 mmol/L; P<.001), and BMI (MD -1.55, 95% CI -2.92 to -0.17 kg/m2; P=.03) were each improved compared to the control group. CONCLUSIONS Digital diabetes management has been shown to effectively improve blood glucose levels and BMI in individuals with T2DM in home settings. A key feature of successful digital health interventions is the frequent SMBG by patients, supported by dedicated health care professionals who provide timely, personalized, and responsive guidance. TRIAL REGISTRATION PROSPERO CRD42024560431; https://tinyurl.com/yfam3nms.
Collapse
Affiliation(s)
- Yuping Xiao
- School of Nursing, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Zhenzhen Wang
- School of Nursing, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Lintao Zhang
- Acupuncture and Moxibustion Department, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China
| | - Nina Xie
- School of Nursing, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Fangyao Chen
- School of Public Health, Xi'an Jiaotong University, Xi'an, China
| | - Zihao Song
- Department of Clinical Medicine of Traditional Chinese and Western Medicine, First School of Clinical Medicine, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Sha Zhao
- Xiangya School of Nursing, Central South University, Changsha, China
| |
Collapse
|
15
|
Lundgrin EL, Kelly CA, Bellini N, Lewis C, Rafi E, Hatipoglu B. Diabetes Technology Trends: A Review of the Latest Innovations. J Clin Endocrinol Metab 2025; 110:S165-S174. [PMID: 39998918 DOI: 10.1210/clinem/dgaf034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2024] [Indexed: 02/27/2025]
Abstract
CONTEXT Over the last decade, diabetes management tools such as continuous glucose monitors, automated insulin delivery systems, and connected insulin pens have experienced exponential growth. These technologies are more readily being adopted to manage diabetes due to increased availability. This mini-review provides information about recent innovations available in the United States for diabetes management to improve patient outcomes. EVIDENCE ACQUISITION A systematic search was conducted using Medline, PubMed, ScienceDirect, and Embase databases, as well as the Cochrane Library to identify peer-reviewed articles published between 2014 and 2024, in English, and focused on treatment using technology in diabetes care. EVIDENCE SYNTHESIS Diabetes technology has significantly eased the burden of both glucose measurement and insulin delivery, which has, overall, improved diabetes management. Advancements in accuracy and glycemic outcomes have been demonstrated through rigorous clinical and observational trials, underscoring their potential to transform diabetes care. The literature suggests that the use of diabetes technologies promotes patient self-efficacy and enhances the quality of life for individuals with both type 2 and type 1 diabetes. CONCLUSION Diabetes technology has been shown to improve important aspects of diabetes care, from glycemic control to patient satisfaction and quality of life. It is important to assess the role of technology in type 1 and type 2 diabetes and individualize treatment goals and objectives.
Collapse
Affiliation(s)
- Erika L Lundgrin
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
- Department of Pediatric Endocrinology, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA
| | - Clare A Kelly
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
| | - Natalie Bellini
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
| | - Claudia Lewis
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
| | - Ebne Rafi
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
| | - Betul Hatipoglu
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
| |
Collapse
|
16
|
Cardona-Hernandez R, de la Cuadra-Grande A, Monje J, Echave M, Oyagüez I, Álvarez M, Leiva-Gea I. Are Trends in Economic Modeling of Pediatric Diabetes Mellitus up to Date with the Clinical Practice Guidelines and the Latest Scientific Findings? JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH 2025; 12:30-50. [PMID: 39911635 PMCID: PMC11797704 DOI: 10.36469/001c.127920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Accepted: 12/30/2024] [Indexed: 02/07/2025]
Abstract
Background: Modeling techniques in the field of pediatrics present unique challenges beyond traditional model limitations, and sometimes difficulties in faithfully simulating the condition's evolution over time. Objective: This study aimed to identify whether economic modeling approaches in diabetes in pediatric patients align with the recommendations of clinical practice guidelines and the latest scientific evidence. Methods: A literature review was performed in March 2023 to identify modeling-based economic evaluations in diabetes in pediatric patients. Data were extracted and synthesized from eligible studies. Clinical practice guidelines for diabetes were gathered to compare their alignment with modeling strategies. Two endocrinology specialists provided insights on the latest findings in diabetes that are not yet included in the guidelines. A multidisciplinary group of experts agreed on the relevant themes to conduct the comparative analysis: parameter informing on glycemic control, diabetic ketoacidosis/hypoglycemia, C-peptide as prognostic biomarker, metabolic memory, age at diagnosis, socioeconomic status, pediatric-specific sources of risk equations, and pediatric-specific sources of utilities/disutilities. Results: Nineteen modeling-based studies (7 de novo, 12 predesigned models) and 34 guidelines were selected. Hemoglobin A1c was the main parameter to model the glycemic control; however, guidelines recommend the usage of complementary measures (eg, time in range) which are not included in economic models. Eight models included diabetic ketoacidosis (42.1%), 16 included hypoglycemia (84.2%), 2 included C-peptide (1 of those as prognostic factor) (10.5%) and 1 included legacy effect (5.3%). Neither guidelines nor models included recent findings, such as age at diagnosis or socioeconomic status, as prognostic factors. The lack of pediatric-specific sources for risk equations and utility/disutility values were additional limitations. Discussion: Economic models designed for assessing interventions in diabetes in pediatric patients should be based on pediatric-specific data and include novel adjuvant glucose-monitoring metrics and latest evidence on prognostic factors (C-peptide, legacy effect, age at diagnosis, socioeconomic status) to provide a more faithful reflection of the disease. Conclusions: Economic models represent useful tools to inform decision making. However, further research assessing the gaps is needed to enhance evidence-based health economic modeling that best represents reality.
Collapse
Affiliation(s)
| | | | - Julen Monje
- Health Economics & Outcomes Research Medtronic (Spain)
| | - María Echave
- Pharmacoeconomics & Outcomes Research Iberia (PORIB)
| | | | - María Álvarez
- Health Economics & Outcomes Research Medtronic (Spain)
| | - Isabel Leiva-Gea
- Department of Pediatric Endocrinology Regional University Hospital of Malaga
| |
Collapse
|
17
|
Idi E, Manzoni E, Facchinetti A, Sparacino G, Favero SD. Unsupervised Retrospective Detection of Pressure Induced Failures in Continuous Glucose Monitoring Sensors for T1D Management. IEEE J Biomed Health Inform 2025; 29:1383-1396. [PMID: 39302774 DOI: 10.1109/jbhi.2024.3465893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/22/2024]
Abstract
Continuous Glucose Monitoring sensors (CGMs) have revolutionized type 1 diabetes (T1D) management. In particular, in several cases, the retrospective analysis of CGM recordings allows clinicians to review and adjust patients' therapy. However, in this set-up, the artifacts that are often present in CGM data could lead to incorrect therapeutic actions. To mitigate this risk, we investigate how to detect one of the most common of these artifacts, the so-called pressure induced sensor attenuations, by means of anomaly detection algorithms. Specifically, these methods belong to the class of unsupervised techniques, which is particularly appealing since it does not require a labeled dataset, hardly available in practice. After having designed five features to highlight the anomalous state of the sensor, 8 different methods (e.g. Isolation Forest and Histogram-based Outlier Score) are assessed both in silico using the UVa/Padova Type 1 Diabetes Simulator and on real data of 36 subjects monitored for about 10 days. In the in silico scenario, the best results are achieved with Isolation Forest, which recognized the 74% of the failures generating on average only 2 false alerts during the whole monitoring time. In real data, Isolation Forest is confirmed to be effective in the detection of failures, achieving a recall of 55% and generating 3 false alarms in 10 days. By allowing to detect more than 50% of the artifacts while discarding only a few portions of correct data in several days of monitoring, the proposed approach could effectively improve the quality of CGM data used by clinicians to retrospectively evaluate and adjust T1D therapy.
Collapse
|
18
|
Rothenbühler M, Lizoain A, Rebeaud F, Perotte A, Stoffel M, DeVries JH. A Prospective Pilot Study Demonstrating Noninvasive Calibration-Free Glucose Measurement. J Diabetes Sci Technol 2025:19322968251313811. [PMID: 39881452 PMCID: PMC11780617 DOI: 10.1177/19322968251313811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2025]
Abstract
BACKGROUND Glucose is an essential molecule in energy metabolism. Dysregulated glucose metabolism, the defining feature of diabetes, requires active monitoring and treatment to prevent significant morbidity and mortality. Current technologies for intermittent and continuous glucose measurement are invasive. Noninvasive glucose measurement would eliminate this barrier toward making glucose monitoring more accessible, extending the benefits from people living with diabetes to prediabetes and the healthy. METHODS A novel spectroscopy-based system for measuring glucose noninvasively was used in an exploratory, prospective, single-center clinical study (NCT06272136) to develop and test a machine learning-based computational model for continuous glucose monitoring without per-subject calibration. The study design blinded the development investigators to the validation analyses. RESULTS Twenty subjects were enrolled. Fifteen were used for the development set, and five in the validation set. All study participants were adults with insulin-treated diabetes and median glycated hemoglobin (HbA1c) of 7.3% (interquartile range [IQR] = 6.7-7.7). The computational model resulted in a mean absolute relative difference (MARD) of 14.5% and 96.5% of the paired glucose data points in the A plus B zones of the Diabetes Technology Society (DTS) error grid. The correlation between the average model sensitivity by wavelength and the spectrum of glucose was 0.45 (P < .001). CONCLUSIONS Our findings suggest that Raman spectroscopy coupled with advanced computational methods can enable continuous, noninvasive glucose measurement without per-subject invasive calibration.
Collapse
|
19
|
Drachuk I, Ramani N, Harbaugh S, Mirkin CA, Chávez JL. Implantable Fluorogenic DNA Biosensor for Stress Detection. ACS APPLIED MATERIALS & INTERFACES 2025; 17:130-139. [PMID: 39417681 DOI: 10.1021/acsami.4c08940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2024]
Abstract
Implantable sensors that can monitor analytes related to cognitive and physiological status have gained significant focus in recent years. We have developed an implantable biosensor to detect dehydroepiandrosterone sulfate (DHEA-S), a biomarker related to stress. The biosensor strategy was based on the principle of forced intercalation (FIT) aptamers designed to detect subtle intramolecular changes during aptamer-target binding events. By incorporating a steroid-specific fluorogenic aptamer into a hydrogel, the sensitivity and biostability of the FIT biosensor fiber were improved, which were essential for designing implantable sensors to monitor biomarker levels in the living body. The polyethylenimine-based hydrogel chosen for this study produced an optically transparent cross-linked network with optimal microstructure, physicochemical, and mechanical properties, making it suitable for optical biosensors. The in vitro studies showed that the biosensor fiber was successfully activated in human serum and skin analogue, providing a linear response to physiological concentrations of the steroid. We believe that this type of implantable platform can be effective in monitoring more complex biomarkers associated with physiological or psychological health.
Collapse
Affiliation(s)
- Irina Drachuk
- 711th Human Performance Wing, Human Effectiveness Directorate, AFRL, 2510 Fifth Street, Wright-Patterson AFB, Ohio 45433, United States
- UES, a BlueHalo Company, 4401 Dayton-Xenia Rd., Dayton, Ohio 45432, United States
| | - Namrata Ramani
- Department of Materials Science and Engineering and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
| | - Svetlana Harbaugh
- 711th Human Performance Wing, Human Effectiveness Directorate, AFRL, 2510 Fifth Street, Wright-Patterson AFB, Ohio 45433, United States
| | - Chad A Mirkin
- Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
| | - Jorge L Chávez
- 711th Human Performance Wing, Human Effectiveness Directorate, AFRL, 2510 Fifth Street, Wright-Patterson AFB, Ohio 45433, United States
| |
Collapse
|
20
|
Healey E, Tan ALM, Flint KL, Ruiz JL, Kohane I. A case study on using a large language model to analyze continuous glucose monitoring data. Sci Rep 2025; 15:1143. [PMID: 39774031 PMCID: PMC11707017 DOI: 10.1038/s41598-024-84003-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2024] [Accepted: 12/18/2024] [Indexed: 01/11/2025] Open
Abstract
Continuous glucose monitors (CGM) provide valuable insights about glycemic control that aid in diabetes management. However, interpreting metrics and charts and synthesizing them into linguistic summaries is often non-trivial for patients and providers. The advent of large language models (LLMs) has enabled real-time text generation and summarization of medical data. The objective of this study was to assess the strengths and limitations of using an LLM to analyze raw CGM data and produce summaries of 14 days of data for patients with type 1 diabetes. We first evaluated the ability of GPT-4 to compute quantitative metrics specific to diabetes found in an Ambulatory Glucose Profile (AGP). Then, using two independent clinician graders, we evaluated the accuracy, completeness, safety, and suitability of qualitative descriptions produced by GPT-4 across five different CGM analysis tasks. GPT-4 performed 9 out of the 10 quantitative metrics tasks with perfect accuracy across all 10 cases. The clinician-evaluated CGM analysis tasks had good performance across measures of accuracy [lowest task mean score 8/10, highest task mean score 10/10], completeness [lowest task mean score 7.5/10, highest task mean score 10/10], and safety [lowest task mean score 9.5/10, highest task mean score 10/10]. Our work serves as a preliminary study on how generative language models can be integrated into diabetes care through data summarization and, more broadly, the potential to leverage LLMs for streamlined medical time series analysis.
Collapse
Affiliation(s)
- Elizabeth Healey
- Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
| | - Amelia Li Min Tan
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA
| | - Kristen L Flint
- Diabetes Research Center, Massachusetts General Hospital, Boston, MA, 02114, USA
- Harvard Medical School, Boston, MA, 02115, USA
| | - Jessica L Ruiz
- Division of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA
- Harvard Medical School, Boston, MA, 02115, USA
| | - Isaac Kohane
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA
| |
Collapse
|
21
|
Liu B, Wu X, Zou X, Sun F, Yu J. Knowledge, Attitudes, and Practices of Chronic Type 2 Diabetes Patients in China Toward Continuous Glucose Monitoring: An Online Questionnaire Survey. Diabetes Metab Syndr Obes 2025; 18:11-22. [PMID: 39802618 PMCID: PMC11720747 DOI: 10.2147/dmso.s487493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 12/21/2024] [Indexed: 01/16/2025] Open
Abstract
Purpose Investigate the knowledge, attitude, and practices (KAP) of type 2 diabetes patients regarding continuous glucose monitoring (CGM). Methods A cross-sectional study was undertaken at the First People's Hospital of Jiujiang City from Sep 20, 2023, to Dec 10, 2023. Results A total of 633 patients with type 2 diabetes mellitus accessed the questionnaire link. Of these, 544 patients completed the questionnaires. After data cleaning, 493 questionnaires were included in the analysis, resulting in a response rate of 86% and an effective rate of 91%. Among the 493 participants, 66.9% were male, and 70.8% reported using continuous glucose monitoring (CGM). Median scores: knowledge 17 (14, 26), attitude 34 (32, 40), and practice 20 (17, 24). Positive correlations existed between knowledge and attitude (r = 0.562, P < 0.001), knowledge and practice (r = 0.653, P < 0.001), and attitude and practice (r = 0.661, P < 0.001). Logistic regression revealed that being male, participating in diabetes education, and possessing higher knowledge and attitude scores were independently associated with positive practices. Structural equation model (SEM) showed knowledge directly influenced attitude (β = 0.538, P = 0.010) and practice (β = 0.433, P = 0.010), while attitude directly influenced practice (β = 0.450, P = 0.010). Knowledge indirectly impacted practice through its influence on attitude (β = 0.242, P = 0.010). Conclusion Type 2 diabetes patients exhibited insufficient knowledge but positive attitudes and practices toward CGM. Recommends educational interventions to enhance knowledge, potentially improving CGM utilization and outcomes in this population. Regular and comprehensive diabetes education should be integrated into routine clinical practice to optimize self-management and overall patient outcomes.
Collapse
Affiliation(s)
- Bingling Liu
- Department of Endocrinology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang, 332000, People’s Republic of China
| | - Xueyi Wu
- Department of Endocrinology, The Second People’s Hospital of Guiyang, Guiyang, 550081, People’s Republic of China
| | - Xiao Zou
- Department of Endocrinology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang, 332000, People’s Republic of China
| | - Fei Sun
- Department of Endocrinology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang, 332000, People’s Republic of China
| | - Jie Yu
- Department of Endocrinology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang, 332000, People’s Republic of China
| |
Collapse
|
22
|
Ojaimi RE, Cheisson G, Cosson E, Ichai C, Jacqueminet S, Nicolescu-Catargi B, Ouattara A, Tauveron I, Valensi P, Benhamou D. Recent advances in perioperative care of patients using new antihyperglycaemic drugs and devices dedicated to diabetes. Anaesth Crit Care Pain Med 2025; 44:101468. [PMID: 39743045 DOI: 10.1016/j.accpm.2024.101468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2024] [Accepted: 08/28/2024] [Indexed: 01/04/2025]
Affiliation(s)
- Rami El Ojaimi
- Department of Anaesthesia and Intensive Care Medicine, Hôpital Henri Mondor, AP-HP, 1, rue Gustave Eiffel, 94000, Créteil, France.
| | - Gaëlle Cheisson
- Department of Anaesthesia and Intensive Care Medicine, Hôpital Bicêtre, AP-HP, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France
| | - Emmanuel Cosson
- Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, University of Paris 13, Sorbonne Paris Cité, CRNH-IdF, CINFO, AP-HP, Bobigny, France; Recherche en Epidémiologie Nutritionnelle (EREN), Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Center of Research in Epidemiology and StatisticS (CRESS), Bobigny, France
| | - Carole Ichai
- Department of Intensive Care Medicine, Université Côte d'Azur, Hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06001 Nice cedex 1, France
| | - Sophie Jacqueminet
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Institute of Cardiometabolism and Nutrition ICAN, Paris, France
| | - Bogdan Nicolescu-Catargi
- Department of Endocrinology ad Metabolic Diseases, Hôpital Saint-André, Bordeaux University Hospital, 1, rue Jean-Burguet, 33000 Bordeaux, France
| | - Alexandre Ouattara
- CHU Bordeaux, Department of Cardiovascular Anaesthesia and Critical Care, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM, UMR 1034, Biology of Cardiovascular Diseases, F-33600 Pessac, France
| | - Igor Tauveron
- Department of Endocrinology and Diabetology, Clermont Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - Paul Valensi
- Polyclinique d'Aubervilliers, Aubervilliers and Université Paris-Nord, Bobigny, France
| | - Dan Benhamou
- Department of Anaesthesia and Intensive Care Medicine, Hôpital Bicêtre, AP-HP, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France.
| |
Collapse
|
23
|
Kongdee R, Parsia B, Thabit H, Harper S. Glucose interpretation meaning and action (GIMA): Insights to blood glucose user interface interpretation in type 1 diabetes. Digit Health 2025; 11:20552076251332580. [PMID: 40351844 PMCID: PMC12062595 DOI: 10.1177/20552076251332580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Accepted: 03/03/2025] [Indexed: 05/14/2025] Open
Abstract
Background Current glucose monitoring user interfaces (UIs) are problematic for people with Type 1 Diabetes Mellitus (T1DM) in maintaining recommended blood glucose levels effectively. However, there is a lack of in-depth investigation into this problem when these individuals interpret and make real-time decisions based on the glucose monitoring devices they use daily. Objectives We aim to investigate problems associated with glucose monitoring UIs by observing users' interpretation and decision-making while reading their Continuous Glucose Monitoring (CGM), Flash Glucose Monitoring (Flash) or Self-monitoring of Blood Glucose (SMBG). Methods A mixed-method study was conducted. The Think Aloud protocol was used to capture participants' decision-making process while reading various device UIs. Their responses were evaluated using standard clinical guidance to assess their accuracy. Additionally, a survey was distributed to gather their perceptions of self-management practices. Results Twenty-seven participants (17 patients and 10 carers) were recruited. Interpretation accuracy averaged 38.0% ± 11.1% for CGM, 39.5% ± 8.8% for Flash, and 33.3% ± 7.8% for SMBG group. Treatment action accuracy was 21.5% ± 15.6% for CGM, 21.2% ± 14.0% for Flash, and 18.0% ± 13.2% for SMBG group. Despite this, 75.0% of all participants expressed very high confidence in their self-management. Conclusions Interpreting and making decisions using glucose monitoring UIs remains significantly challenging for people with T1DM despite their self-perceived performance. Improving such UIs is crucial to reduce misinterpretation and help these individuals make better treatment decisions without relying on their potentially inaccurate interpretations.
Collapse
Affiliation(s)
- Rujiravee Kongdee
- Department of Computer Science, University of Manchester, Manchester, UK
| | - Bijan Parsia
- Department of Computer Science, University of Manchester, Manchester, UK
| | - Hood Thabit
- Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Simon Harper
- Department of Computer Science, University of Manchester, Manchester, UK
| |
Collapse
|
24
|
Chen S, Lu J, Peng D, Liu F, Lu W, Zhu W, Bao Y, Zhou J, Jia W. The status of blood glucose monitoring and its influencing factors in Chinese patients with type 2 diabetes initiating premixed insulin: A prospective real-world study. Diabetes Res Clin Pract 2024; 218:111895. [PMID: 39424147 DOI: 10.1016/j.diabres.2024.111895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2024] [Revised: 09/25/2024] [Accepted: 10/16/2024] [Indexed: 10/21/2024]
Abstract
OBJECTIVE This study aimed to assess the current state of self-monitoring of blood glucose (SMBG) in Chinese patients initiating premixed insulin and its influential factors. RESEARCH DESIGN AND METHODS This is a single-arm, multi-center, prospective real-world study enrolling a total of 8214 adult patients with type 2 diabetes mellitus (T2DM) newly initiated premixed insulin analogues. Each patient was followed up for 12 weeks, and the data related to SMBG was collected at week 1, week 4, week 8 and week 12, while data related to glycated hemoglobin were collected at week 1 and week 12. The primary outcome was the frequency of SMBG over 12 weeks. RESULTS At week 12, 83.3 % monitored blood glucose at least once, while 20.3 % of participants continued SMBG every week. The average monitoring frequency was 4.78 times/week over the first 4 weeks and 3.33 times/week over 12 weeks. The patients with a higher frequency of SMBG had better control of blood glucose. CONCLUSIONS This study found that most T2DM patients would take SMBG but the adherence decreased over time. The adherence to SMBG in Chinese T2DM patients was influenced by age, insulin dosage, education level, and diabetes duration. SMBG benefited the improvement of glycemic control.
Collapse
Affiliation(s)
- Si Chen
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Jingyi Lu
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Danfeng Peng
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Fengjing Liu
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Wei Lu
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Wei Zhu
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Yuqian Bao
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China
| | - Jian Zhou
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China.
| | - Weiping Jia
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China.
| |
Collapse
|
25
|
Song J, McNeany J, Wang Y, Daley T, Stecenko A, Kamaleswaran R. Riemannian manifold-based geometric clustering of continuous glucose monitoring to improve personalized diabetes management. Comput Biol Med 2024; 183:109255. [PMID: 39405732 DOI: 10.1016/j.compbiomed.2024.109255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2024] [Revised: 10/02/2024] [Accepted: 10/05/2024] [Indexed: 11/20/2024]
Abstract
BACKGROUND Continuous Glucose Monitoring (CGM) provides a detailed representation of glucose fluctuations in individuals, offering a rich dataset for understanding glycemic control in diabetes management. This study explores the potential of Riemannian manifold-based geometric clustering to analyze and interpret CGM data for individuals with Type 1 Diabetes (T1D) and healthy controls (HC), aiming to enhance diabetes management and treatment personalization. METHODS We utilized CGM data from publicly accessible datasets, covering both T1D individuals on insulin and HC. Data were segmented into daily intervals, from which 27 distinct glycemic features were extracted. Uniform Manifold Approximation and Projection (UMAP) was then applied to reduce dimensionality and visualize the data, with model performance validated through correlation analysis between Silhouette Score (SS) against HC cluster and HbA1c levels. RESULTS UMAP effectively distinguished between T1D on daily insulin and HC groups, with data points clustering according to glycemic profiles. Moderate inverse correlations were observed between SS against HC cluster and HbA1c levels, supporting the clinical relevance of the UMAP-derived metric. CONCLUSIONS This study demonstrates the utility of UMAP in enhancing the analysis of CGM data for diabetes management. We revealed distinct clustering of glycemic profiles between healthy individuals and diabetics on daily insulin indicating that in most instances insulin does not restore a normal glycemic phenotype. In addition, the SS quantifies day by day the degree of this continued dysglycemia and therefore potentially offers a novel approach for personalized diabetes care.
Collapse
Affiliation(s)
- Jiafeng Song
- Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 30332, GA, USA; Department of Biomedical Informatics, Emory University, Atlanta, 30322, GA, USA; Department of Biomedical Engineering, Duke University, Durham, 27708, NC, USA.
| | - Jocelyn McNeany
- Department of Pediatrics, Emory University, Atlanta, 30322, GA, USA
| | - Yifei Wang
- Department of Biological Sciences, Georgia Institute of Technology, Atlanta, 30322, GA, USA
| | - Tanicia Daley
- Department of Pediatrics, Emory University, Atlanta, 30322, GA, USA
| | - Arlene Stecenko
- Department of Pediatrics, Emory University, Atlanta, 30322, GA, USA
| | - Rishikesan Kamaleswaran
- Department of Biomedical Engineering, Duke University, Durham, 27708, NC, USA; Department of Surgery, Duke University School of Medicine, Durham, 27708, NC, USA; Department of Anesthesiology, Duke University, Durham, 27708, NC, USA; Department of Electrical and Computer Engineering, Duke University, Durham, 27708, NC, USA
| |
Collapse
|
26
|
Baker J, Cappon G, Habineza JC, Basch CH, Mey S, Malkin-Washeim DL, Schuetz C, Simon Pierre N, Uwingabire E, Mukamazimpaka A, Mbonyi P, Narayanan S. Continuous Glucose Monitoring Among Patients with Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Feasibility Study. JMIR Form Res 2024; 9:e64585. [PMID: 39592231 PMCID: PMC11774321 DOI: 10.2196/64585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2024] [Revised: 11/21/2024] [Accepted: 11/25/2024] [Indexed: 11/28/2024] Open
Abstract
BACKGROUND The development of minimally invasive continuous glucose monitoring systems (CGMs) has transformed diabetes management. CGMs have shown clinical significance by improving time in the euglycemic range, decreasing rates of hypoglycemia, and improving HbA1c. In Rwanda, CGMs are currently not in routine use, and no clinical studies of CGM use were identified in the literature. OBJECTIVE To determine impact and feasibility of real-time CGM use among people living with T1D in Rwanda, through assessment of sensor usage, time in range, rates of hypo-and-hyperglycemia, HbA1c and rates of diabetes-related hospitalizations over time. METHODS The Continuous Glucose Monitoring Among Patients with Type 1 Diabetes in Rwanda (CAPT1D) study is a single-arm prospective observational study conducted at the Rwandan Diabetes Association (RDA) clinic in Kigali, Rwanda, aiming to assess the impact and feasibility of CGM use in Rwanda. A cohort of 50 participants diagnosed with T1D were enrolled. Participants were at least 21 years old, undergoing multiple daily insulin therapy, and not currently pregnant. Phase I of the study was conducted over 12 months, using the Dexcom G6 CGM. Phase II and Phase III extended CGM use for an additional 6 months respectively, using the next generation, Dexcom G7 CGM. Here we report the quantitative results of the Phase I study. RESULTS Participants used the sensor for >80% of the time throughout the study period. A significant increase in time in range was observed within 3 months, and sustained over 12 months. HbA1c decreased significantly in 3 months and stayed lower throughout the 12-month period. Mean HbA1c levels decreased by 2.8% at 6 months (p<0.01) and 3.2% at 12 months (p<0.01) A total of 12 diabetes-related hospitalizations were reported during the study period. No cases of DKA or episodes of severe hypoglycemia occurred. CONCLUSIONS Significant and meaningful improvements in key glycemic indices indicate the potential feasibility and impact of CGM among people living with T1D in Rwanda. Future studies could be designed to include pre- and post-intervention analysis to determine the effectiveness in terms of complications and costs. CLINICALTRIAL
Collapse
Affiliation(s)
- Jason Baker
- Diabetes Empowerment International, New York, NY, United States
| | - Giacomo Cappon
- Department of Information Engineering, University of Padova, Padova, Italy
| | - Jean Claude Habineza
- Rwanda Diabetes Association, Kigali, Rwanda
- School of Health Sciences, University of Rwanda, Kigali, Rwanda
| | - Corey H Basch
- Diabetes Empowerment International, New York, NY, United States
| | - Steven Mey
- Diabetes Empowerment International, New York, NY, United States
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Colvin L, Al Husseini D, Tu D, Dunlap D, Lalonde T, Üçüncü M, Megia-Fernandez A, Bradley M, Liu W, Grunlan MA, Coté GL. Computational Model-Assisted Development of a Nonenzymatic Fluorescent Glucose-Sensing Assay. ACS Sens 2024; 9:6218-6227. [PMID: 39536779 PMCID: PMC11590106 DOI: 10.1021/acssensors.4c02117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Revised: 10/25/2024] [Accepted: 11/07/2024] [Indexed: 11/16/2024]
Abstract
Deep-red fluorescence was implemented in this fully injectable, nonenzymatic glucose biosensor design to allow for better light penetration through the skin, particularly for darker skin tones. In this work, a novel method was developed to synthesize Cy5.5 labeled mannose conjugates (Cy5.5-mannobiose, Cy5.5-mannotriose, and Cy5.5-mannotetraose) to act as the fluorescent competing ligand in a competitive binding assay with the protein Concanavalin A acting as the recognition molecule. Using fluorescence anisotropy (FA) data, a computational model was developed to determine optimal concentration ratios of the assay components to allow for sensitive glucose measurements within the physiological range. The model was experimentally validated by measuring the glucose response via FA of the three Cy5.5-labeled mannose conjugates synthesized with Cy5.5-mannotetraose demonstrating the most sensitive response to glucose across the physiological range. The developed method may be broadly applied to a vast range of commercially available fluorescent dyes and opens up opportunities for glucose measurements using nonenzymatic assays.
Collapse
Affiliation(s)
- Lydia Colvin
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Center for
Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States
| | - Diana Al Husseini
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Center for
Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States
| | - Dandan Tu
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Center for
Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States
| | - Darin Dunlap
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
| | - Tyler Lalonde
- Department
of Chemistry, Texas A&M University, College Station, Texas 77843, United States
| | - Muhammed Üçüncü
- School
of
Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, U.K.
| | | | - Mark Bradley
- School
of
Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, U.K.
| | - Wenshe Liu
- Department
of Chemistry, Texas A&M University, College Station, Texas 77843, United States
| | - Melissa A. Grunlan
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Center for
Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States
- Department
of Chemistry, Texas A&M University, College Station, Texas 77843, United States
| | - Gerard L. Coté
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Center for
Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States
- Department
of Electrical and Computer Engineering, Texas A&M University, College
Station, Texas 77843, United States
| |
Collapse
|
28
|
Liu X, Zhang J. Continuous Glucose Monitoring: A Transformative Approach to the Detection of Prediabetes. J Multidiscip Healthc 2024; 17:5513-5519. [PMID: 39600717 PMCID: PMC11590642 DOI: 10.2147/jmdh.s493128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2024] [Accepted: 11/14/2024] [Indexed: 11/29/2024] Open
Abstract
Prediabetes, as an intermediary stage between normal glucose homeostasis and overt diabetes, affects an estimated 720 million individuals worldwide, highlighting the urgent need for proactive intervention strategies. Continuous glucose monitoring (CGM) emerges as a transformative tool, offering unprecedented insights into glycemic dynamics and facilitating tailored therapeutic interventions. This perspective scores the clinical significance of even slightly elevated fasting blood glucose levels and the critical role of early intervention. CGM technology provides real-time, continuous data on glucose concentrations, surpassing the constraints of conventional monitoring methods. Both retrospectively analyzed and real-time CGM systems offer valuable tools for glycemic management, each with unique strengths. The integration of CGM into routine care can detect early indicators of type 2 diabetes, inform the development of personalized intervention strategies, and foster patient engagement and empowerment. Despite challenges such as cost and the need for effective utilization through training and education, CGM's potential to revolutionize prediabetes management is evident. Future research should focus on refining CGM algorithms, exploring personalized intervention strategies, and leveraging wearable technology and artificial intelligence advancements to optimize glycemic control and patient well-being.
Collapse
Affiliation(s)
- Xueen Liu
- Department of Nursing, Beijing Hepingli Hospital, Beijing, People’s Republic of China
| | - Jiale Zhang
- Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China
| |
Collapse
|
29
|
Song HJ, Han JH, Cho SP, Im SI, Kim YS, Park JU. Predicting Dysglycemia in Patients with Diabetes Using Electrocardiogram. Diagnostics (Basel) 2024; 14:2489. [PMID: 39594155 PMCID: PMC11592764 DOI: 10.3390/diagnostics14222489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2024] [Revised: 10/21/2024] [Accepted: 11/05/2024] [Indexed: 11/28/2024] Open
Abstract
Background: In this study, we explored the potential of predicting dysglycemia in patients who need to continuously manage blood glucose levels using a non-invasive method via electrocardiography (ECG). Methods: The data were collected from patients with diabetes, and heart rate variability (HRV) features were extracted via ECG processing. A residual block-based one-dimensional convolution neural network model was used to predict dysglycemia. Results: The dysglycemia prediction results at each time point, including at the time of blood glucose measurement, 15 min prior to measurement, and 30 min prior to measurement, exhibited no significant differences compared with the blood glucose measurement values. This result confirmed that the proposed artificial intelligence model for dysglycemia prediction performed well at each time point. Additionally, to determine the optimal number of features required for predicting dysglycemia, 77 HRV features were individually eliminated in the order of decreasing importance with respect to the prediction accuracy; the optimal number of features for the model to predict dysglycemia was determined to be 12. The dysglycemia prediction results obtained 30 min prior to measurement, which exhibited the highest prediction range in this study, were as follows: accuracy = 90.5, sensitivity = 87.52, specificity = 92.74, and precision = 89.86. Conclusions: Furthermore, we determined that no significant differences exist in the blood glucose prediction results reported in previous studies, wherein various vital signs and blood glucose values were used as model inputs, and the results obtained in this study, wherein only ECG data were used to predict dysglycemia.
Collapse
Affiliation(s)
- Ho-Jung Song
- Department of Medical Engineering, Konyang University, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon 32992, Republic of Korea; (H.-J.S.); (J.-H.H.)
| | - Ju-Hyuck Han
- Department of Medical Engineering, Konyang University, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon 32992, Republic of Korea; (H.-J.S.); (J.-H.H.)
| | - Sung-Pil Cho
- MEZOO Co., Ltd., RM.808 200, Gieopdosi-ro, Jijeong-myeon, Wonju-si 26354, Republic of Korea;
| | - Sung-Il Im
- Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan 49267, Republic of Korea;
| | - Yong-Suk Kim
- Department of Artificial Intelligence, Konyang University, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon 32992, Republic of Korea;
| | - Jong-Uk Park
- Department of Artificial Intelligence, Konyang University, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon 32992, Republic of Korea;
| |
Collapse
|
30
|
Haluzík M, Al-Sofiani ME, Cheng AYY, Lauand F, Melas-Melt L, Rosenstock J. Time-in-range derived from self-measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant-level pooled analysis of three phase 3 LixiLan randomized controlled trials. Diabetes Obes Metab 2024; 26:5046-5055. [PMID: 39245809 DOI: 10.1111/dom.15811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 07/04/2024] [Accepted: 07/04/2024] [Indexed: 09/10/2024]
Abstract
AIM To evaluate the efficacy of a fixed-ratio combination of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) in people with type 2 diabetes (T2D) using derived time-in-range (dTIR). METHODS Participant-level data from LixiLan-L, LixiLan-O and LixiLan-G were pooled and dTIR (70-180 mg/dL), derived time-above-range (> 180 mg/dL) and derived time-below-range (dTBR; < 70 mg/dL) were calculated from participant seven-point self-monitored blood glucose profiles. RESULTS This pooled analysis included data from 2420 participants receiving iGlarLixi (n = 1093), iGlar (n = 836), Lixi (n = 234) or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) (n = 257). Numerically greater improvements in least square (LS) means dTIR were seen from baseline to end of treatment (EOT) with iGlarLixi (25.7%) versus iGlar (15.8%), Lixi (11.7%) or GLP-1 RA (16.2%). At EOT, the mean (standard deviation) dTBR was 0.71% ± 3.4%, 0.61% ± 3.2%, 0.08% ± 1.0% and 0.0% ± 0.0% for iGlarLixi, iGlar, Lixi and GLP-1 RA, respectively. In a subgroup analysis, participants aged younger than 65 years (n = 1690) and 65 years or older (n = 713) showed numerically greater improvements in LS means dTIR from baseline to EOT with iGlarLixi versus iGlar, Lixi or GLP-1 RA. CONCLUSIONS iGlarLixi achieved improvements in dTIR, with low dTBR values, providing further evidence to inform clinical outcomes with the use of iGlarLixi.
Collapse
Affiliation(s)
- Martin Haluzík
- Diabetes Centre, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
| | - Mohammed E Al-Sofiani
- Department of Internal Medicine, King Saud University, Riyadh, Saudi Arabia
- Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University, Baltimore, Maryland, USA
| | - Alice Y Y Cheng
- Department of Medicine, University of Toronto, Toronto, Canada
| | | | | | - Julio Rosenstock
- Velocity Clinical Research at Medical City Dallas, Dallas, Texas, USA
| |
Collapse
|
31
|
Sabben G, Telfort C, Morales M, Zhang WS, Espinoza JC, Pasquel FJ, Winskell K. Technology and Continuous Glucose Monitoring Access, Literacy, and Use Among Patients at the Diabetes Center of an Inner-City Safety-Net Hospital: Mixed Methods Study. JMIR Diabetes 2024; 9:e54223. [PMID: 39405528 PMCID: PMC11522655 DOI: 10.2196/54223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Revised: 08/08/2024] [Accepted: 08/23/2024] [Indexed: 11/02/2024] Open
Abstract
BACKGROUND Despite the existence of an increasing array of digital technologies and tools for diabetes management, there are disparities in access to and uptake and use of continuous glucose monitoring (CGM) devices, particularly for those most at risk of poor diabetes outcomes. OBJECTIVE This study aims to assess communication technology and CGM access, literacy, and use among patients receiving treatment for diabetes at an inner-city safety-net hospital. METHODS A survey on digital technology ownership and use was self-administered by 75 adults with type 1 and type 2 diabetes at the diabetes clinic of Grady Memorial Hospital in Atlanta, Georgia. In-depth interviews were conducted with 16% (12/75) of these patient participants and 6 health care providers (HCPs) to obtain additional insights into the use of communication technology and CGM to support diabetes self-management. RESULTS Most participants were African American (66/75, 88%), over half (39/75, 52%) were unemployed or working part time, and 29% (22/75) had no health insurance coverage, while 61% (46/75) had federal coverage. Smartphone ownership and use were near universal; texting and email use were common (63/75, 84% in both cases). Ownership and use of tablets and computers and use and daily use of various forms of media were more prevalent among younger participants and those with type 1 diabetes, who also rated them as easier to use. Technology use specifically for diabetes and health management was low. Participants were supportive of a potential smartphone app for diabetes management, with a high interest in such an app helping them track blood sugar levels and communicate with their care teams. Younger participants showed higher levels of interest, perceived value, and self-efficacy for using an app with these capabilities. History of CGM use was reported by 56% (42/75) of the participants, although half (20/42, 48%) had discontinued use, above all due to the cost of the device and issues with its adhesive. Nonuse was primarily due to not being offered CGM by their HCP. Reasons given for continued use included convenience, improved blood glucose control, and better tracking of blood glucose. The in-depth interviews (n=18) revealed high levels of satisfaction with CGM by users and supported the survey findings regarding reasons for continued use. They also highlighted the value of CGM data to enhance communication between patients and HCPs. CONCLUSIONS Smartphone ownership was near universal among patients receiving care at an inner-city hospital. Alongside the need to address barriers to CGM access and continued use, there is an opportunity to leverage increased access to communication technology in combination with CGM to improve diabetes outcomes among underresourced populations.
Collapse
Affiliation(s)
- Gaëlle Sabben
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - Courtney Telfort
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - Marissa Morales
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - Wenjia Stella Zhang
- Center for the Study of Human Health, College of Arts and Sciences, Emory University, Atlanta, GA, United States
| | - Juan C Espinoza
- Division of Hospital Based Medicine, Department of Pediatrics, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, United States
| | - Francisco J Pasquel
- Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Kate Winskell
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| |
Collapse
|
32
|
Li J, Ma J, Omisore OM, Liu Y, Tang H, Ao P, Yan Y, Wang L, Nie Z. Noninvasive Blood Glucose Monitoring Using Spatiotemporal ECG and PPG Feature Fusion and Weight-Based Choquet Integral Multimodel Approach. IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS 2024; 35:14491-14505. [PMID: 37289613 DOI: 10.1109/tnnls.2023.3279383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
change of blood glucose (BG) level stimulates the autonomic nervous system leading to variation in both human's electrocardiogram (ECG) and photoplethysmogram (PPG). In this article, we aimed to construct a novel multimodal framework based on ECG and PPG signal fusion to establish a universal BG monitoring model. This is proposed as a spatiotemporal decision fusion strategy that uses weight-based Choquet integral for BG monitoring. Specifically, the multimodal framework performs three-level fusion. First, ECG and PPG signals are collected and coupled into different pools. Second, the temporal statistical features and spatial morphological features in the ECG and PPG signals are extracted through numerical analysis and residual networks, respectively. Furthermore, the suitable temporal statistical features are determined with three feature selection techniques, and the spatial morphological features are compressed by deep neural networks (DNNs). Lastly, weight-based Choquet integral multimodel fusion is integrated for coupling different BG monitoring algorithms based on the temporal statistical features and spatial morphological features. To verify the feasibility of the model, a total of 103 days of ECG and PPG signals encompassing 21 participants were collected in this article. The BG levels of participants ranged between 2.2 and 21.8 mmol/L. The results obtained show that the proposed model has excellent BG monitoring performance with a root-mean-square error (RMSE) of 1.49 mmol/L, mean absolute relative difference (MARD) of 13.42%, and Zone A + B of 99.49% in tenfold cross-validation. Therefore, we conclude that the proposed fusion approach for BG monitoring has potentials in practical applications of diabetes management.
Collapse
|
33
|
Thullen A, Gerber R, Keen A. Glycemic Outcomes and Nurse Perceptions of Continuous Glucose Monitoring for Hospitalized Patients. J Nurs Care Qual 2024; 39:310-316. [PMID: 39167920 DOI: 10.1097/ncq.0000000000000791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/23/2024]
Abstract
BACKGROUND Continuous glucose monitoring (CGM) can decrease hypoglycemic events and health care costs; however, barriers and facilitators that influence CGM use are unknown. PURPOSE The purpose of this study was to evaluate hypoglycemic events and cost outcomes after CGM implementation and describe associated barriers and facilitators. METHODS A mixed-methods study design was used to evaluate CGM implementation on 2 pulmonary units within an academic health center. Hypoglycemic events were evaluated before and after CGM implementation, and nurses were interviewed about facilitators and barriers that influence CGM use. RESULTS Hypoglycemic events decreased from a rate of 0.0906 per 1000 patient days to 0.0503 postimplementation, P < .0001. A $105 766 cost avoidance was recognized. Barriers and facilitators to CGM use are described. CONCLUSIONS Findings support CGM implementation, while uniquely contributing financial impact and device use barriers and facilitators. Hospitals may consider CGM use to improve timely identification and treatment of hypoglycemia.
Collapse
Affiliation(s)
- Alexandra Thullen
- Authors Affiliations: Nursing Quality, Adult Academic Health Center, Indiana University Health, Indianapolis, Indiana (Thullen, Gerber, and Keen)
| | | | | |
Collapse
|
34
|
Tecce N, Menafra D, Proganò M, Tecce MF, Pivonello R, Colao A. Evaluating the Impact of Continuous Glucose Monitoring on Erectile Dysfunction in Type 1 Diabetes: A Focus on Reducing Glucose Variability and Inflammation. Healthcare (Basel) 2024; 12:1823. [PMID: 39337164 PMCID: PMC11430976 DOI: 10.3390/healthcare12181823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2024] [Revised: 09/06/2024] [Accepted: 09/09/2024] [Indexed: 09/30/2024] Open
Abstract
Type 1 diabetes (T1D) severely impairs metabolic control and can lead to erectile dysfunction (ED) through hyperglycemia-induced vascular damage, autonomic neuropathy, and psychological distress. This review examines the role of continuous glucose monitoring (CGM) in ameliorating ED by addressing glucose variability and inflammation. A comprehensive analysis of studies and clinical trials was conducted to evaluate the impact of CGM on metabolic control, inflammatory responses, and vascular health in patients with T1D. Evidence suggests that CGM systems significantly stabilize blood glucose levels and reduce hyper- and hypoglycemic episodes that contribute to endothelial dysfunction and ED. CGM's real-time feedback helps patients optimize metabolic control, improve vascular health, and reduce inflammation. CGM has the potential to redefine ED management in patients with T1D by improving glycemic control and reducing the physiological stressors that cause ED, potentially improving quality of life and sexual health. Further research is warranted to explore the specific benefits of CGM for ED management.
Collapse
Affiliation(s)
- Nicola Tecce
- Department of Clinical Medicine and Surgery, Department of Endocrinology, University Federico II of Naples, 80138 Naples, Italy; (D.M.); (M.P.); (R.P.); (A.C.)
| | - Davide Menafra
- Department of Clinical Medicine and Surgery, Department of Endocrinology, University Federico II of Naples, 80138 Naples, Italy; (D.M.); (M.P.); (R.P.); (A.C.)
| | - Mattia Proganò
- Department of Clinical Medicine and Surgery, Department of Endocrinology, University Federico II of Naples, 80138 Naples, Italy; (D.M.); (M.P.); (R.P.); (A.C.)
| | - Mario Felice Tecce
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy;
| | - Rosario Pivonello
- Department of Clinical Medicine and Surgery, Department of Endocrinology, University Federico II of Naples, 80138 Naples, Italy; (D.M.); (M.P.); (R.P.); (A.C.)
- UNESCO Chair for Health Education and Sustainable Development, University Federico II of Naples, 80138 Naples, Italy
| | - Annamaria Colao
- Department of Clinical Medicine and Surgery, Department of Endocrinology, University Federico II of Naples, 80138 Naples, Italy; (D.M.); (M.P.); (R.P.); (A.C.)
- UNESCO Chair for Health Education and Sustainable Development, University Federico II of Naples, 80138 Naples, Italy
| |
Collapse
|
35
|
Adalian D, Madero X, Chen S, Jilani M, Smith RD, Li S, Ahlbrecht C, Cardenas J, Agarwal A, Emami A, Plettenburg O, Petillo PA, Scherer A. Patterned thin film enzyme electrodes via spincoating and glutaraldehyde vapor crosslinking: towards scalable fabrication of integrated sensor-on-CMOS devices. LAB ON A CHIP 2024; 24:4172-4181. [PMID: 39099534 DOI: 10.1039/d4lc00206g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/06/2024]
Abstract
Effective continuous glucose monitoring solutions require consistent sensor performance over the lifetime of the device, a manageable variance between devices, and the capability of high volume, low cost production. Here we present a novel and microfabrication-compatible method of depositing and stabilizing enzyme layers on top of planar electrodes that can aid in the mass production of sensors while also improving their consistency. This work is focused on the fragile biorecognition layer as that has been a critical difficulty in the development of microfabricated sensors. We test this approach with glucose oxidase (GOx) and evaluate the sensor performance with amperometric measurements of in vitro glucose concentrations. Spincoating was used to deposit a uniform enzyme layer across a wafer, which was subsequently immobilized via glutaraldehyde vapor crosslinking and patterned via liftoff. This yielded an approximately 300 nm thick sensing layer which was applied to arrays of microfabricated platinum electrodes built on blank wafers. Taking advantage of their planar array format, measurements were then performed in high-throughput parallel instrumentation. Due to their thin structure, the coated electrodes exhibited subsecond stabilization times after the bias potential was applied. The deposited enzyme layers were measured to provide a sensitivity of 2.3 ± 0.2 μA mM-1 mm-2 with suitable saturation behavior and minimal performance shift observed over extended use. The same methodology was then demonstrated directly on top of wireless CMOS potentiostats to build a monolithic sensor with similar measured performance. This work demonstrates the effectiveness of the combination of spincoating and vapor stabilization processes for wafer scale enzymatic sensor functionalization and the potential for scalable fabrication of monolithic sensor-on-CMOS devices.
Collapse
Affiliation(s)
- Dvin Adalian
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Xiomi Madero
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Samson Chen
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Musab Jilani
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Richard D Smith
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Songtai Li
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Christin Ahlbrecht
- Institute for Medicinal Chemistry, Molecular Targets and Therapeutics Center, Helmholtz Center Munich, Neuherberg, Germany
| | - Juan Cardenas
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Abhinav Agarwal
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Azita Emami
- California Institute of Technology, Pasadena, CA 91125, USA.
| | - Oliver Plettenburg
- Institute for Medicinal Chemistry, Molecular Targets and Therapeutics Center, Helmholtz Center Munich, Neuherberg, Germany
| | - Peter A Petillo
- Design-Zyme LLC, 4950 Research Park Way, Lawrence, Kansas 66047, USA
| | - Axel Scherer
- California Institute of Technology, Pasadena, CA 91125, USA.
| |
Collapse
|
36
|
Thomas A, Haak T, Tombek A, Kulzer B, Ehrmann D, Kordonouri O, Kröger J, Schubert-Olesen O, Kolassa R, Siegmund T, Haller N, Heinemann L. How to Use Continuous Glucose Monitoring Efficiently in Diabetes Management: Opinions and Recommendations by German Experts on the Status and Open Questions. J Diabetes Sci Technol 2024:19322968241267768. [PMID: 39129243 PMCID: PMC11571508 DOI: 10.1177/19322968241267768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/13/2024]
Abstract
Today, continuous glucose monitoring (CGM) is a standard diagnostic option for patients with diabetes, at least for those with type 1 diabetes and those with type 2 diabetes on insulin therapy, according to international guidelines. The switch from spot capillary blood glucose measurement to CGM was driven by the extensive and immediate support and facilitation of diabetes management CGM offers. In patients not using insulin, the benefits of CGM are not so well studied/obvious. In such patients, factors like well-being and biofeedback are driving CGM uptake and outcome. Apps can combine CGM data with data about physical activity and meal consumption for therapy adjustments. Personalized data management and coaching is also more feasible with CGM data. The same holds true for digitalization and telemedicine intervention ("virtual diabetes clinic"). Combining CGM data with Smart Pens ("patient decision support") helps to avoid missing insulin boluses or insulin miscalculation. Continuous glucose monitoring is a major pillar of all automated insulin delivery systems, which helps substantially to avoid acute complications and achieve more time in the glycemic target range. These options were discussed by a group of German experts to identify concrete gaps in the care structure, with a view to the necessary structural adjustments of the health care system.
Collapse
Affiliation(s)
| | - Thomas Haak
- Diabetes consulting, Mergentheim Diabetes Center, Bad Mergentheim, Germany
| | - Astrid Tombek
- Diabetes consulting, Mergentheim Diabetes Center, Bad Mergentheim, Germany
| | - Bernhard Kulzer
- Diabetes consulting, Mergentheim Diabetes Center, Bad Mergentheim, Germany
- FIDAM, Forschungsinstitut Diabetes-Akademie Mergentheim (Diabetes Academy Mergentheim Research Institute), Bad Mergentheim, Germany
| | - Dominic Ehrmann
- FIDAM, Forschungsinstitut Diabetes-Akademie Mergentheim (Diabetes Academy Mergentheim Research Institute), Bad Mergentheim, Germany
| | - Olga Kordonouri
- AUF DER BULT Hospital, Diabetes Center for Children and Adolescents, Hannover, Germany
| | - Jens Kröger
- Diabetes, Hamburg City Diabetes Center, Hamburg, Germany
| | | | - Ralf Kolassa
- Diabetes, Diabetes Focus Practice Bergheim/Erft, Bergheim/Erft, Germany
| | | | - Nicola Haller
- Diabetes, Diabetes & Metabolic Center Starnberg, Starnberg, Germany
| | - Lutz Heinemann
- Science Consulting in Diabetes GmbH, Düsseldorf, Germany
| |
Collapse
|
37
|
Kalita D, Sharma H, Mirza KB. Continuous Glucose, Insulin and Lifestyle Data Augmentation in Artificial Pancreas Using Adaptive Generative and Discriminative Models. IEEE J Biomed Health Inform 2024; 28:4963-4974. [PMID: 38709612 DOI: 10.1109/jbhi.2024.3396880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/08/2024]
Abstract
Artificial pancreas requires data from multiple sources for accurate insulin dose estimation. These include data from continuous glucose sensors, past insulin dosage information, meal quantity and time and physical activity data. The effectiveness of closed-loop diabetes management systems might be hampered by the absence of these data caused by device error or lack of compliance by patients. In this study, we demonstrate the effect of output sequence length-driven generative and discriminative model selection in high quality data generation and augmentation. This novel generative adversarial network (GAN) based architecture automatically selects the generator and discriminator architecture based on the desired output sequence length. The proposed model is able to generate glucose, physical activity, meal information data for individual patients. The discriminative scores for Ohio T1DM (2018) dataset were 0.17 ±0.03 (Inputs: CGM, CHO, Insulin) and 0.15 ±0.02 (Inputs: CGM, CHO, Insulin, Heart Rate, Steps) and for Ohio T1D (2020) dataset was 0.16 ±0.02 (Inputs: CGM, CHO, Insulin) and 0.15 ±0.02 (Inputs: CGM, CHO, Insulin, acceleration). A mixture of generated and real data was used to test predictive scores for glucose forecasting models. The best RMSE and MARD achieved for OhioT1DM patients were 17.19 ±3.22 and 7.14 ±1.76 for PH=30 min with CGM, CHO, Insulin, heartrate and steps as inputs. Similarly, the RMSE and MARD for real+synthetic data were 15.63 ±2.57 and 5.86 ±1.69 respectively. Compared to existing generative models, we demonstrate that sequence length based architecture selection leads to better synthetic data generation for multiple output sequences (CGM, CHO, Insulin) and forecasting accuracy.
Collapse
|
38
|
Bahal M, Pande V, Dua J, Mane S. Advances in Type 1 Diabetes Mellitus Management in Children. Cureus 2024; 16:e67377. [PMID: 39310514 PMCID: PMC11416143 DOI: 10.7759/cureus.67377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2024] [Accepted: 08/21/2024] [Indexed: 09/25/2024] Open
Abstract
Recent advancements in the management of type 1 diabetes mellitus (T1DM) have significantly improved outcomes and quality of life for patients, particularly children. Technological innovations, such as continuous glucose monitoring (CGM) systems and insulin pump therapy, including hybrid closed-loop systems, have enhanced glycemic control by providing real-time data and automated insulin delivery. Ultrarapid-acting insulins and adjunctive pharmacotherapies, like sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists, offer improved postprandial glucose management and reduced insulin requirements. Immunotherapy and beta-cell replacement therapies, including stem cell research and encapsulation devices, aim to preserve or restore endogenous insulin production. Digital health platforms and telemedicine have expanded access to education and support, fostering better self-management. Future directions in precision medicine, artificial intelligence, and microbiome research hold promise for personalized and potentially curative treatments. Collectively, these advances are transforming T1DM management, reducing disease burden, and enhancing the prospects for children with T1DM.
Collapse
Affiliation(s)
- Mridu Bahal
- Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND
| | - Vineeta Pande
- Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND
| | - Jasleen Dua
- Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND
| | - Shailaja Mane
- Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND
| |
Collapse
|
39
|
Mauldin K, Pignotti GAP, Gieng J. Measures of nutrition status and health for weight-inclusive patient care: A narrative review. Nutr Clin Pract 2024; 39:751-771. [PMID: 38796769 DOI: 10.1002/ncp.11158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 04/07/2024] [Accepted: 04/25/2024] [Indexed: 05/28/2024] Open
Abstract
In healthcare, weight is often equated to and used as a marker for health. In examining nutrition and health status, there are many more effective markers independent of weight. In this article, we review practical and emerging clinical applications of technologies and tools used to collect non-weight-related data in nutrition assessment, monitoring, and evaluation in the outpatient setting. The aim is to provide clinicians with new ideas about various types of data to evaluate and track in nutrition care.
Collapse
Affiliation(s)
- Kasuen Mauldin
- Department of Nutrition, Food Science, and Packaging, San Jose State University, San Jose, California, USA
- Clinical Nutrition, Stanford Health Care, Stanford, California, USA
| | - Giselle A P Pignotti
- Department of Nutrition, Food Science, and Packaging, San Jose State University, San Jose, California, USA
| | - John Gieng
- Department of Nutrition, Food Science, and Packaging, San Jose State University, San Jose, California, USA
| |
Collapse
|
40
|
Origlia C, Rodriguez-Duarte DO, Tobon Vasquez JA, Bolomey JC, Vipiana F. Review of Microwave Near-Field Sensing and Imaging Devices in Medical Applications. SENSORS (BASEL, SWITZERLAND) 2024; 24:4515. [PMID: 39065913 PMCID: PMC11280878 DOI: 10.3390/s24144515] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 07/05/2024] [Accepted: 07/09/2024] [Indexed: 07/28/2024]
Abstract
Microwaves can safely and non-destructively illuminate and penetrate dielectric materials, making them an attractive solution for various medical tasks, including detection, diagnosis, classification, and monitoring. Their inherent electromagnetic properties, portability, cost-effectiveness, and the growth in computing capabilities have encouraged the development of numerous microwave sensing and imaging systems in the medical field, with the potential to complement or even replace current gold-standard methods. This review aims to provide a comprehensive update on the latest advances in medical applications of microwaves, particularly focusing on the near-field ones working within the 1-15 GHz frequency range. It specifically examines significant strides in the development of clinical devices for brain stroke diagnosis and classification, breast cancer screening, and continuous blood glucose monitoring. The technical implementation and algorithmic aspects of prototypes and devices are discussed in detail, including the transceiver systems, radiating elements (such as antennas and sensors), and the imaging algorithms. Additionally, it provides an overview of other promising cutting-edge microwave medical applications, such as knee injuries and colon polyps detection, torso scanning and image-based monitoring of thermal therapy intervention. Finally, the review discusses the challenges of achieving clinical engagement with microwave-based technologies and explores future perspectives.
Collapse
Affiliation(s)
- Cristina Origlia
- Department of Electronics and Telecommunications, Politecnico di Torino, 10129 Torino, Italy; (C.O.); (D.O.R.-D.); (J.A.T.V.)
| | - David O. Rodriguez-Duarte
- Department of Electronics and Telecommunications, Politecnico di Torino, 10129 Torino, Italy; (C.O.); (D.O.R.-D.); (J.A.T.V.)
| | - Jorge A. Tobon Vasquez
- Department of Electronics and Telecommunications, Politecnico di Torino, 10129 Torino, Italy; (C.O.); (D.O.R.-D.); (J.A.T.V.)
| | | | - Francesca Vipiana
- Department of Electronics and Telecommunications, Politecnico di Torino, 10129 Torino, Italy; (C.O.); (D.O.R.-D.); (J.A.T.V.)
| |
Collapse
|
41
|
Kong SY, Cho MK. Development and Effectiveness of a Pattern Management Educational Program Using Continuous Glucose Monitoring for Type 2 Diabetic Patients in Korea: A Quasi-Experimental Study. Healthcare (Basel) 2024; 12:1381. [PMID: 39057524 PMCID: PMC11275423 DOI: 10.3390/healthcare12141381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2024] [Revised: 07/07/2024] [Accepted: 07/09/2024] [Indexed: 07/28/2024] Open
Abstract
BACKGROUND The prevalence of diabetes has increased worldwide. Therefore, interest in improving glycemic control for diabetes has grown, and continuous glucose monitoring (CGM) has recently received attention as an effective glycemic control method. This study developed and evaluated the effectiveness of an education program for pattern management using CGM based on Whittemore and Roy's middle-range theory of adapting to diabetes mellitus. METHODS A quasi-experimental study was conducted on 50 adult patients with type 2 diabetes who visited the outpatient clinic of a university hospital. The experimental group was treated with a pattern management program using CGM for 12 weeks and six personalized education sessions were provided to the patients through face-to-face education and phone monitoring. RESULTS The frequency of diabetes-related symptoms in the experimental group decreased, and social support (t = 2.95, p = 0.005), perceived benefits (t = 3.72, p < 0.001) and self-care significantly increased (t = 6.09, p < 0.001). Additionally, the program was found to be effective in improving HbA1c (t = -3.83, p < 0.001), FBS (t = -2.14, p = 0.038), and HDL-C (t = 2.39, p = 0.021). CONCLUSION The educational program developed through this study can be implemented as a self-management approach for individuals with type 2 diabetes using CGM, aimed at enhancing glycemic control and preventing complications.
Collapse
Affiliation(s)
- Seung-Yeon Kong
- Referral Center, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea;
| | - Mi-Kyoung Cho
- Department of Nursing Science, Research Institute of Nursing Science, Chungbuk National University, Cheongju 28644, Republic of Korea
| |
Collapse
|
42
|
Lejk A, Myśliwiec K, Michalak A, Pernak B, Fendler W, Myśliwiec M. Comparison of Metabolic Control in Children and Adolescents Treated with Insulin Pumps. CHILDREN (BASEL, SWITZERLAND) 2024; 11:839. [PMID: 39062288 PMCID: PMC11275477 DOI: 10.3390/children11070839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 07/05/2024] [Accepted: 07/08/2024] [Indexed: 07/28/2024]
Abstract
BACKGROUND While insulin pumps remain the most common form of therapy for youths with type 1 diabetes (T1DM), they differ in the extent to which they utilize data from continuous glucose monitoring (CGM) and automate insulin delivery. METHODS The aim of the study was to compare metabolic control in patients using different models of insulin pumps. This retrospective single-center study randomly sampled 30 patients for each of the following treatments: Medtronic 720G without PLGS (predictive low glucose suspend), Medtronic 640G or 740G with PLGS and Medtronic 780G. In the whole study group, we used CGM systems to assess patients' metabolic control, and we collected lipid profiles. In three groups of patients, we utilized CGM sensors (Guardian 3, Guardian 4, Libre 2 and Dexcom G6) to measure the following glycemic variability proxy values: time in range (TIR), time below 70 mg/dL (TBR), time above 180 mg/dL (TAR), coefficient of variation (CV) and mean sensor glucose. RESULTS Medtronic 640G or 740G and 780G users were more likely to achieve a target time in the target range 70-180 mg/dL (≥80%) [Medtronic 720G = 4 users (13.3%) vs. Medtronic 640G/740G = 10 users (33.3%) vs. Medtronic 780G = 13 users (43.3%); p = 0.0357)] or low glucose variability [Medtronic 720G = 9 users (30%) vs. Medtronic 640G/740G = 18 users (60%) vs. Medtronic 780G = 19 users (63.3%); p = 0.0175)]. CONCLUSIONS Any integration between the insulin pump and CGM was associated with better glycemic control. More advanced technologies and artificial intelligence in diabetes help patients maintain better glycemia by eliminating various factors affecting postprandial glycemia.
Collapse
Affiliation(s)
- Agnieszka Lejk
- Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, 80-210 Gdansk, Poland; (A.L.)
| | - Karolina Myśliwiec
- Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, 80-210 Gdansk, Poland; (A.L.)
| | - Arkadiusz Michalak
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland
- Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, 91-738 Lodz, Poland
| | - Barbara Pernak
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland
| | - Wojciech Fendler
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland
| | - Małgorzata Myśliwiec
- Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, 80-210 Gdansk, Poland; (A.L.)
| |
Collapse
|
43
|
Kim JY, Jin SM, Sim KH, Kim BY, Cho JH, Moon JS, Lim S, Kang ES, Park CY, Kim SG, Kim JH. Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Diabetologia 2024; 67:1223-1234. [PMID: 38639876 DOI: 10.1007/s00125-024-06152-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2023] [Accepted: 02/19/2024] [Indexed: 04/20/2024]
Abstract
AIMS/HYPOTHESIS The aim of this study was to compare the effectiveness of stand-alone intermittently scanned continuous glucose monitoring (isCGM) with or without a structured education programme and blood glucose monitoring (BGM) in adults with type 2 diabetes on multiple daily insulin injections (MDI). METHODS In this 24 week randomised open-label multicentre trial, adults with type 2 diabetes on intensive insulin therapy with HbA1c levels of 58-108 mmol/mol (7.5-12.0%) were randomly assigned in a 1:1:1 ratio to isCGM with a structured education programme on adjusting insulin dose and timing according to graphical patterns in CGM (intervention group), isCGM with conventional education (control group 1) or BGM with conventional education (control group 2). Block randomisation was conducted by an independent statistician. Due to the nature of the intervention, blinding of participants and investigators was not possible. The primary outcome was change in HbA1c from baseline at 24 weeks, assessed using ANCOVA with the baseline value as a covariate. RESULTS A total of 159 individuals were randomised (n=53 for each group); 148 were included in the full analysis set, with 52 in the intervention group, 49 in control group 1 and 47 in control group 2. The mean (± SD) HbA1c level at baseline was 68.19±10.94 mmol/mol (8.39±1.00%). The least squares mean change (± SEM) from baseline HbA1c at 24 weeks was -10.96±1.35 mmol/mol (-1.00±0.12%) in the intervention group, -6.87±1.39 mmol/mol (-0.63±0.13%) in control group 1 (p=0.0367 vs intervention group) and -6.32±1.42 mmol/mol (-0.58±0.13%) in control group 2 (p=0.0193 vs intervention group). Adverse events occurred in 28.85% (15/52) of individuals in the intervention group, 26.42% (14/53) in control group 1 and 48.08% (25/52) in control group 2. CONCLUSIONS/INTERPRETATION Stand-alone isCGM offers a greater reduction in HbA1c in adults with type 2 diabetes on MDI when education on the interpretation of graphical patterns in CGM is provided. TRIAL REGISTRATION ClinicalTrials.gov NCT04926623. FUNDING This study was supported by Daewoong Pharmaceutical Co., Ltd.
Collapse
Affiliation(s)
- Ji Yoon Kim
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Sang-Man Jin
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Kang Hee Sim
- Diabetes Education Unit, Diabetes Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Bo-Yeon Kim
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea
| | - Jae Hyoung Cho
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Jun Sung Moon
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea
| | - Soo Lim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Eun Seok Kang
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
| | - Cheol-Young Park
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Sin Gon Kim
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
| | - Jae Hyeon Kim
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
44
|
Healey E, Kohane I. Model-Based Insulin Sensitivity and Beta-Cell Function Estimation from Daily Continuous Glucose Monitoring. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2024; 2024:1-4. [PMID: 40038964 DOI: 10.1109/embc53108.2024.10781685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/06/2025]
Abstract
Type 2 diabetes (T2D) is a prevalent chronic illness with many different options for treatment management. Continuous glucose monitors (CGM) offer physiological data that clinicians can access when making treatment decisions. However, the utility of CGM in management of T2D remains an active area of research. In our work, we demonstrate the feasibility of exploiting raw daily CGM data to estimate the physiological parameters of insulin sensitivity and beta-cell function that correlate with estimates derived from laboratory findings. We use a peak extraction algorithm to extract peaks from daily CGM data and implement a model-based approach to infer physiological parameters. We demonstrate that the inferred parameter estimates of insulin sensitivity and beta-cell function correlate to the ground truth measurements as determined by an oral glucose tolerance test (OGTT).
Collapse
|
45
|
Chimene D, Queener KMK, Ko BS, McShane M, Daniele M. Insertable Biosensors: Combining Implanted Sensing Materials with Wearable Monitors. Annu Rev Biomed Eng 2024; 26:197-221. [PMID: 38346276 DOI: 10.1146/annurev-bioeng-110222-101045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/05/2024]
Abstract
Insertable biosensor systems are medical diagnostic devices with two primary components: an implantable biosensor within the body and a wearable monitor that can remotely interrogate the biosensor from outside the body. Because the biosensor does not require a physical connection to the electronic monitor, insertable biosensor systems promise improved patient comfort, reduced inflammation and infection risk, and extended operational lifetimes relative to established percutaneous biosensor systems. However, the lack of physical connection also presents technical challenges that have necessitated new innovations in developing sensing chemistries, transduction methods, and communication modalities. In this review, we discuss the key developments that have made insertables a promising option for longitudinal biometric monitoring and highlight the essential needs and existing development challenges to realizing the next generation of insertables for extended-use diagnostic and prognostic devices.
Collapse
Affiliation(s)
- David Chimene
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA;
| | - Kirstie M K Queener
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel Hill, Raleigh, North Carolina, USA
| | - Brian S Ko
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA;
| | - Mike McShane
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA;
- Department of Materials Science and Engineering, Texas A&M University, College Station, Texas, USA
| | - Michael Daniele
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel Hill, Raleigh, North Carolina, USA
- Department of Electrical and Computer Engineering, North Carolina State University, Raleigh, North Carolina, USA;
| |
Collapse
|
46
|
Chimene D, Saleem W, Longbottom N, Ko B, Jeevarathinam AS, Horn S, McShane MJ. Long-Term Evaluation of Inserted Nanocomposite Hydrogel-Based Phosphorescent Oxygen Biosensors: Evolution of Local Tissue Oxygen Levels and Foreign Body Response. ACS APPLIED BIO MATERIALS 2024; 7:3964-3980. [PMID: 38809780 PMCID: PMC11190996 DOI: 10.1021/acsabm.4c00336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Revised: 05/08/2024] [Accepted: 05/09/2024] [Indexed: 05/31/2024]
Abstract
Phosphorescence-based oxygen-sensing hydrogels are a promising platform technology for an upcoming generation of insertable biosensors that are smaller, softer, and potentially more biocompatible than earlier designs. However, much remains unknown about their long-term performance and biocompatibility in vivo. In this paper, we design and evaluate a range of hydrogel sensors that contain oxygen-sensitive phosphors stabilized by micro- and nanocarrier systems. These devices demonstrated consistently good performance and biocompatibility in young adult rats for over three months. This study thoroughly establishes the biocompatibility and long-term suitability of phosphorescence lifetime sensors in vivo, providing the groundwork for expansion of this platform technology into a family of small, unobtrusive biosensors for a range of clinically relevant metabolites.
Collapse
Affiliation(s)
- David Chimene
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
| | - Waqas Saleem
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
| | - Nichole Longbottom
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Department
of Veterinary Anatomy and Pathobiology, Texas A&M University, College Station, Texas 77843, United States
| | - Brian Ko
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
| | | | - Staci Horn
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Department
of Veterinary Anatomy and Pathobiology, Texas A&M University, College Station, Texas 77843, United States
| | - Michael J. McShane
- Department
of Biomedical Engineering, Texas A&M
University, College
Station, Texas 77843, United States
- Department
of Materials Science & Engineering, Texas A&M University, College Station, Texas 77843, United States
| |
Collapse
|
47
|
Turner LV, Riddell MC. Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems. Diabetes Obes Metab 2024; 26:2492-2496. [PMID: 38433709 DOI: 10.1111/dom.15532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2023] [Revised: 02/14/2024] [Accepted: 02/16/2024] [Indexed: 03/05/2024]
Affiliation(s)
- Lauren V Turner
- Muscle Health Research Centre, York University, Toronto, Ontario, Canada
| | - Michael C Riddell
- Muscle Health Research Centre, York University, Toronto, Ontario, Canada
| |
Collapse
|
48
|
Zamponi V, Haxhi J, Pugliese G, Faggiano A, Mazzilli R. Diabetes technology and sexual health: which role? J Endocrinol Invest 2024; 47:1315-1321. [PMID: 37987916 PMCID: PMC11142995 DOI: 10.1007/s40618-023-02237-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 10/30/2023] [Indexed: 11/22/2023]
Abstract
PURPOSE The aim of this review is to evaluate the effects of new technology used in the management of diabetes mellitus (DM), including the use of continuous glucose monitoring (CGM) and the administration of insulin through continuous subcutaneous insulin infusion (CSII), on male and female sexual function. METHODS This narrative review was performed for all available prospective, retrospective and review articles, published up to June 2023 in PubMed. Data were extracted from the text and from the tables of the manuscript. RESULTS Sexual dysfunctions are an underestimated comorbidity of DM in both male and female. Although erectile dysfunction (ED) is recognized by the guidelines as a complication of DM, female sexual dysfunction (FSD) is poorly investigated in clinical setting. In addition to the complications of DM, the different types of therapies can also influence male and female sexual response. Furthermore, insulin therapy can be administered through multiple-daily injections (MDI) or a CSII. The new technologies in the field of DM allow better glycemic control which results in a reduction in the occurrence or aggravation of complications of DM. Despite this evidence, few data are available on the impact of new technologies on sexual dysfunctions. CONCLUSIONS The use of DM technology might affect sexual function due to the risk of a worse body image, as well as discomfort related to CSII disconnection during sexual activity. However, the use is related to an improved metabolic control, which, in the long-term associates to a reduction in all diabetes complications, including sexual function.
Collapse
Affiliation(s)
- V Zamponi
- Endocrine-Metabolic Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, via di Grottarossa, 1035-1039, Rome, Italy
| | - J Haxhi
- Endocrine-Metabolic Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, via di Grottarossa, 1035-1039, Rome, Italy
| | - G Pugliese
- Endocrine-Metabolic Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, via di Grottarossa, 1035-1039, Rome, Italy
| | - A Faggiano
- Endocrine-Metabolic Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, via di Grottarossa, 1035-1039, Rome, Italy
| | - R Mazzilli
- Endocrine-Metabolic Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, via di Grottarossa, 1035-1039, Rome, Italy.
| |
Collapse
|
49
|
Villa-Tamayo MF, Builes-Montaño CE, Ramirez-Rincón A, Carvajal J, Rivadeneira PS. Accuracy of an Off-Label Transmitter and Data Manager Paired With an Intermittent Scanned Continuous Glucose Monitor in Adults With Type 1 Diabetes. J Diabetes Sci Technol 2024; 18:701-708. [PMID: 36281579 PMCID: PMC11089852 DOI: 10.1177/19322968221133405] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND This work evaluates the accuracy and agreement between the FreeStyle Libre sensor (FSL) and an off-label converted real-time continuous glucose monitor (c-rtCGM) device consisting of the MiaoMiao transmitter and the xDrip+ application which can be coupled to the FSL. METHODS Four weeks of glucose data were collected from 21 participants with type 1 diabetes using the c-rtCGM and FSL: two weeks with a single initial calibration (uncalibrated) and two weeks with a daily calibration (calibrated). Accuracy and agreement evaluation included mean absolute relative difference (MARD), the %20/20 rule, Bland-Altman plots, and the Consensus Error Grid analysis. RESULTS Values reported by the c-rtCGM system compared with the FSL resulted in an overall MARD of 12.06% and 84.71% of the results falling within Consensus Error Grid Zone A when the device is calibrated. For uncalibrated devices, an overall MARD of 17.49% was obtained. Decreased accuracy was shown in the hypoglycemic range and for rates of change greater than 2 mg/dL/min. The between-device bias also incremented with increasing glucose values. CONCLUSION Measurements recorded by the c-rtCGM were found to be accurate when compared with FSL data only when performing daily c-rtCGM device calibrations. High drops in accuracy and agreement between devices occurred when the c-rtCGM was not calibrated.
Collapse
Affiliation(s)
- María F. Villa-Tamayo
- Department of Engineering Systems and Environment, University of Virginia, Charlottesville, VA, USA
| | | | - Alex Ramirez-Rincón
- Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin, Colombia
- Clínica Integral de Diabetes, Medellín, Colombia
| | | | - Pablo S. Rivadeneira
- Grupo GITA, Facultad de Minas, Universidad Nacional de Colombia, Medellín, Colombia
| |
Collapse
|
50
|
Chen S, Wu P, Zhang T, Zhang J, Gao H. Global scientific trends on the islet transplantation in the 21st century: A bibliometric and visualized analysis. Medicine (Baltimore) 2024; 103:e37945. [PMID: 38669398 PMCID: PMC11049693 DOI: 10.1097/md.0000000000037945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Accepted: 03/29/2024] [Indexed: 04/28/2024] Open
Abstract
BACKGROUND Islet transplantation (IT) has emerged as a significant research area for the treatment of diabetes mellitus and has witnessed a surge in scholarly attention. Despite its growing importance, there is a lack of bibliometric analyses that encapsulate the evolution and scientific underpinnings of this field. This study aims to fill this gap by conducting a comprehensive bibliometric analysis to delineate current research hotspots and forecast future trajectories within the IT domain with a particular focus on evidence-based medicine practices. METHODS This analysis scrutinized literature from January 1, 2000, to October 1, 2023, using the Web of Science Core Collection (WoSCC). Employing bibliometric tools such as VOSviewer, CiteSpace, and the R package "bibliometrix," we systematically evaluated the literature to uncover scientific trends and collaboration networks in IT research. RESULTS The analysis revealed 8388 publications from 82 countries, predominantly the United States and China. However, global cross-institutional collaboration in IT research requires further strengthening. The number of IT-related publications has increased annually. Leading research institutions in this field include Harvard University, the University of Alberta, the University of Miami, and the University of Minnesota. "Transplantation" emerges as the most frequently cited journal in this area. Shapiro and Ricordi were the most prolific authors, with 126 and 121 publications, respectively. Shapiro also led to co-citations, totaling 4808. Key research focuses on IT sites and procedures as well as novel therapies in IT. Emerging research hotspots are identified by terms like "xenotransplantation," "apoptosis," "stem cells," "immunosuppression," and "microencapsulation." CONCLUSIONS The findings underscore a mounting anticipation for future IT research, which is expected to delve deeper into evidence-based methodologies for IT sites, procedures, and novel therapeutic interventions. This shift toward evidence-based medicine underscores the field's commitment to enhancing the efficacy and safety of IT for diabetes treatment, signaling a promising direction for future investigations aimed at optimizing patient outcomes.
Collapse
Affiliation(s)
- Sheng Chen
- Graduate School, Guangxi University of Chinese Medicine, Nanning, China
| | - PeiZhong Wu
- Graduate School, Guangxi University of Chinese Medicine, Nanning, China
| | - Ting Zhang
- Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, China
| | - Jianqiang Zhang
- Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, China
| | - Hongjun Gao
- Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, China
| |
Collapse
|